Document:

EX-10.2

 Exhibit 10.2 

Execution Copy 
  

			
	 BNP PARIBAS SECURITIES CORP.

BNP PARIBAS
 787 Seventh
Avenue
 New York, New York 10019
	  	 THE BANK OF NOVA SCOTIA

250 Vesey Street
 New York, New York
10281

 CONFIDENTIAL 

August 1, 2017 
 Jacobs Engineering Group
Inc. 
 1999 Bryan Street, Suite 1200 
 Dallas, Texas 75201 

Attention: 
 Project Charlotte 

$1,600,000,000 Senior Unsecured Revolving Credit Facility 

Commitment Letter 
 Ladies &
Gentlemen: 
 You have informed each of BNP Paribas (“BNPP”), BNP Paribas Securities Corp.
(“BNPPSC” and, together with BNPP, “BNP Paribas”) and The Bank of Nova Scotia (“Scotiabank”, together with BNP Paribas, the “Commitment Parties”,
“we” or “us”) that Jacobs Engineering Group Inc. and its subsidiaries (the “Company” or “you”) intend to acquire, through a merger (the
“Acquisition”), the company you have identified to us as “Project Charlotte” and its subsidiaries (collectively, the “Acquired Business”) in a transaction that will result in you owning the
Acquired Business. 
 You have further informed us that: 

(a) you intend the financing for the Acquisition will include a $1,200,000,000 senior unsecured delayed-draw term loan facility (the
“Term Loan Facility) as described in that certain letter agreement among us and you, of even date herewith (the “Term Loan Facility Commitment Letter”); 

(b) (x) you are party to that certain Amended and Restated Credit Agreement, dated as of February 7, 2014 (as amended, modified or
supplemented from time to time and in effect as of the date hereof , the “Existing Revolving Credit Agreement”), among the Company, certain subsidiaries of the Company, the several lenders from time to time parties thereto,
each issuer of letters of credit from time to time party hereto, and Bank of America, N.A., as administrative agent and swing line lender and (y) you intend to solicit the approvals required under the Existing Revolving Credit Agreement for
certain consents and amendments that would permit the closing of the Acquisition without any further consents from the Lenders and subject to no conditions other than the conditions in the Conditions Schedules (as defined below) (such consents and
amendments collectively, the “Amendment”; the approvals required under the Existing Revolving Credit Agreement in connection with such Amendment, the “Required Approvals”); and 

(c) solely in the event that the Required Approvals are not obtained for any reason (such event, an “Amendment
Failure”), you intend that financing for the Transaction will also include a new $1,600,000,000 senior unsecured revolving credit facility (the “New Revolving Credit Facility”). 

  
 1 

 Capitalized terms used but not defined herein are used with the meanings assigned to them in the
Summary of Terms and Conditions attached hereto as Annex A (the “Term Sheet”), the Schedule of Conditions Precedent to the New Revolving Credit Facility on the Closing Date attached hereto as Annex B
(“Conditions to Closing Schedule”) and the Schedule of Conditions Precedent to the New Revolving Credit Facility on the Funding Date attached hereto as Annex C (“Conditions to Funding Schedule”,
and together with the Conditions to Closing Schedule, the “Conditions Schedules”, and the Term Sheet, the Conditions Schedules and this letter, collectively, the “Commitment Letter”). The Acquisition,
the Term Loan Facility, the repayment of certain existing indebtedness of the Acquired Business, the Amendment, or if the Required Approvals are not obtained for any reason, the New Revolving Credit Facility, and the payment of related fees and
expenses are hereinafter referred to collectively as the “Transaction”. 
 1. Engagement, Commitments and
Conditions. 
 Amendment. Subject to the terms and conditions described in this Commitment Letter and in the confidential fee
letter between you and us of even date herewith (the “Fee Letter”), we are pleased to confirm the arrangements under which each of BNPPSC and Scotiabank will commit to use their commercially reasonable efforts to solicit the
Required Approvals and arrange the Amendment (in such capacity, the “Amendment Arrangers”). For the avoidance of doubt, this commitment to use commercially reasonable efforts to solicit the Required Approvals and
arrange the Amendment is not a guarantee with respect to the successful outcome of the Amendment and does not constitute or give rise to a commitment to purchase commitments with respect to or loans under the Existing Revolving Credit Facility in
order to ensure the successful outcome of the Amendment. 
 New Revolving Credit Facility. Subject to the terms and conditions
described in this Commitment Letter and in the confidential Fee Letter, we are pleased to confirm (but solely in the event of an Amendment Failure) that (a) each of BNPPSC and Scotiabank is exclusively authorized by you to act, and each of
BNPPSC and Scotiabank hereby agree to act, as the joint lead arrangers and joint bookrunners (in such capacities, the “New Revolving Credit Facility Arrangers” and, together with the Amendment Arrangers, the “Lead
Arrangers”) for the New Revolving Credit Facility, (b) BNPP is exclusively authorized by you to act, and BNPP hereby agrees to act, as the administrative agent (in such capacity, the “Administrative Agent”)
for the New Revolving Credit Facility, (c) the Lead Arrangers will manage the syndication of the New Revolving Credit Facility to a syndicate of banks, financial institutions and other persons that will participate in the New Revolving Credit
Facility and that are reasonably acceptable to us and to you (your consent not to be unreasonably withheld or delayed) (such banks, financial institutions and other persons, including BNPP and Scotiabank, the “Lenders”), and
(d) each of BNPP and Scotiabank (in such capacity, the “Initial Lenders”) commits, on a several but not joint basis, to provide the principal amount of the New Revolving Credit Facility set forth opposite such Commitment
Party’s name on Schedule I attached hereto (for the avoidance of doubt, in each case, after giving effect to any original issue discount as contemplated herein or in the Fee Letter). 

The commitments of the Initial Lenders hereunder and the undertaking of the Lead Arrangers to provide the services described herein are
subject only to the satisfaction of each of the conditions precedent set forth in the Conditions Schedules. For the avoidance of doubt, the commitment of the Initial Lenders shall automatically and immediately terminate upon the occurrence, prior to
or concurrent with the consummation of the Acquisition, of the receipt of the Required Approvals. 
 2. Solicitation and Syndication.

 Amendment. The Lead Arrangers intend to commence the solicitation of the Required Approvals and the arrangement of the Amendment
promptly following the date hereof. You agree to assist, and use your commercially reasonable efforts to cause the Acquired Business to assist, the Lead Arrangers in attempting to solicit the Required Approvals and arrange the Amendment. Such
assistance shall include your using commercially reasonable efforts to (a) provide the Lead Arrangers with all information reasonably deemed necessary by the Lead Arrangers to obtain the Required Approvals and arrange the

  
 2 

 
Amendment, including, but not limited to, all customary information with respect to the Acquired Business, the Transaction and the other transactions contemplated hereby, including, the
Projections (as defined below); (b) assist in the preparation of customary marketing materials to be used in connection with the solicitation of the Required Approvals and arrangement of the Amendment; (c) ensure that the solicitation and
arrangement efforts of the Lead Arrangers benefits materially from your existing lending relationships and the existing banking relationships of the Acquired Business; (d) cause direct contact between your senior management, representatives and
advisors (and your using commercially reasonable efforts to cause direct contact between senior management, representatives and advisors of the Acquired Business) and the lenders under Existing Revolving Credit Agreement (the “Existing
Revolving Lenders”) and the Lead Arrangers; and (e) host, with the Lead Arrangers, one or more meetings (including telephonically) of the Existing Revolving Lenders at times and locations to be mutually agreed upon (and your using
commercially reasonable efforts to cause senior management of the Acquired Business to be available for such meetings). 
 New Revolving
Credit Facility. In the event of an Amendment Failure, the Lead Arrangers intend to commence syndication of the New Revolving Credit Facility promptly following an Amendment Failure, and until the earlier of (i) a Successful Syndication and
(ii) 60 days after the Closing Date (the earlier thereof, the “Syndication Date”), you agree to assist, and use your commercially reasonable efforts to cause, the Acquired Business to assist, the Lead Arrangers in
attempting to achieve a Successful Syndication. Such assistance shall include your using commercially reasonable efforts to (a) provide the Lead Arrangers with all information reasonably deemed necessary by the Lead Arrangers to achieve a
Successful Syndication, including, but not limited to, all customary information with respect to the Acquired Business, the Transaction and the other transactions contemplated hereby, including all customary financial information and customary
projections relating to the Acquired Business (including financial estimates, budgets, forecasts and other forward-looking information for the life of the New Revolving Credit Facility, the “Projections”); (b) assist in
the preparation of a customary confidential information memorandum (the “Confidential Information Memorandum”) and other customary marketing materials to be used in connection with the syndication of the New Revolving Credit
Facility; (c) ensure that the syndication efforts of the Lead Arrangers benefit materially from your existing lending relationships and the existing banking relationships of the Acquired Business; (d) cause direct contact between your
senior management, representatives and advisors (and your using commercially reasonable efforts to cause direct contact between senior management, representatives and advisors of the Acquired Business) and the proposed Lenders and the Lead
Arrangers; and (e) host, with the Lead Arrangers, one or more meetings (including telephonically) of prospective Lenders at times and locations to be mutually agreed upon (and your using commercially reasonable efforts to cause senior
management of the Acquired Business to be available for such meetings). 
 You acknowledge that the Lead Arrangers on your behalf will make
available an information package and presentation to the Existing Revolving Lenders or proposed syndicate of Lenders by posting the information package and presentation on DebtDomain, SyndTrak, IntraLinks or another similar electronic system. You
also acknowledge that certain Existing Revolving Lenders or prospective Lenders may be “public side” Lenders (i.e., Existing Revolving Lenders or Lenders that have personnel that do not wish to receive material non-public information
(within the meaning of the United States federal securities laws) with respect to you, the Acquired Business, your or its subsidiaries, the respective securities of any of the foregoing or the Transaction and who may be engaged in investment and
other market-related activities with respect to such entities’ securities). At the reasonable request of the Lead Arrangers, you agree to assist in the preparation of a version of the information package and presentation consisting exclusively
of information and documentation with respect to the Acquired Business, the Acquired Business’ securities and the Transaction that is either (a) information is publicly available, (b) not material with respect to you, the Acquired
Business, your or its respective subsidiaries, the Transaction or any of your or their respective securities for purposes of United States federal and state securities laws or (c) of a type that would be publicly disclosed in connection with
any issuance by the 

  
 3 

 
Acquired Business or any of their respective subsidiaries of any debt or equity securities issued pursuant to a public offering, Rule 144A offering or other private placement where assisted by a
placement agent (all such information and documentation being “Public Lender Information” and with any information and documentation that is not Public Lender Information being referred to herein as “Private Lender
Information”). It is understood that in connection with your assistance described above, customary authorization letters will be included in any information package and presentation whereby you or the Acquired Business authorize the
distribution of such information to Existing Revolving Lenders or prospective Lenders, containing a representation by you or the Acquired Business to the Lead Arrangers that the Public Lender Information does not include information about the
Company, its subsidiaries or its securities other than as described in clauses (a) through (c) above, and the Public Lender Information will contain customary language exculpating us, our affiliates, you, the Acquired Business and your and
their affiliates with respect to any liability related to the use of the contents of such Public Lender Information or any related marketing material by the recipients thereof in violation of applicable securities laws. You acknowledge and agree
that the following documents may be distributed to potential Lenders wishing to receive only the Public Lender Information (unless you promptly notify us otherwise and provided that you have been given a reasonable opportunity to review such
documents): (x) drafts and final definitive documentation with respect to the Amendment or, if applicable, the New Revolving Credit Facility (excluding, if applicable, any specifically identified confidential schedules thereof);
(y) administrative materials prepared by the Lead Arrangers for Existing Revolving Lenders or prospective Lenders (such as a Lender meeting invitation, allocations and funding and closing memoranda (but excluding any projections)); and
(z) notification of changes in the terms of the Amendment or, if applicable, the New Revolving Credit Facility. You also agree to identify that portion of any other Information (as defined below) as relating to you or the Acquired Business (the
“Acquired Business Materials”) to be distributed to “public side” Lenders and that you will clearly and conspicuously mark such materials “PUBLIC” which, at a minimum, shall mean that the word
“PUBLIC” shall appear prominently on the first page thereof. By marking the Acquired Materials “PUBLIC,” you shall be deemed to have authorized the Lead Arrangers and the proposed Lenders to treat the Acquired Business Materials
as not containing any information with respect to the Acquired Business Materials or its securities other than as described in clauses (a) through (c) above. You agree that, unless expressly identified as Public Lender Information, each
document to be disseminated by the Lead Arrangers to any Lender in connection with the New Revolving Credit Facility will be deemed to contain Private Lender Information (except with respect to those documents described in clauses (x), (y) and
(z) of the second preceding sentence). 
 To ensure an orderly and effective solicitation of the Required Approvals or, if applicable,
the syndication of the New Revolving Credit Facility and the commitments provided herein, you agree that, after your acceptance hereof but and until the later of the Closing Date and the Syndication Date, (i) you will not and will not permit
any of your affiliates to, and (ii) you will use commercially reasonable efforts to cause the Acquired Business and its subsidiaries not to, in each case, solicit or attempt to solicit the Required Approvals, arrange or attempt to arrange the
Amendment, syndicate or issue, attempt to syndicate or issue, announce or authorize the announcement of the syndication or issuance of any offering, placement or arrangement of any debt securities or syndicated bank financing (other than
(a) indebtedness incurred in the ordinary course of business for general corporate purposes and consistent with past practices for capital expenditures and working capital purposes, (b) the Term Loan Facility, (c) revolving borrowings
and letters of credit issued under the Existing Revolving Credit Agreement or, if applicable, the New Revolving Credit Facility, in each case, incurred in the ordinary course of business for general corporate purposes consistent with past practices
and (d) indebtedness permitted to be incurred and/or remain outstanding under the Acquisition Agreement as in effect on the date hereof, if any (“Permitted Surviving Debt”)) by or on behalf of you, the Acquired Business
or any of your or the Acquired Business’ subsidiaries, without the prior written consent of the Lead Arrangers if such solicitation of Required Approvals, arrangement of the Amendment or debt securities or syndicated bank financing would have,
in the reasonable judgment of the Lead Arrangers, a detrimental effect upon the solicitation of the Required Approvals, arrangement of the Amendment or primary syndication of the New Revolving Credit Facility. 

  
 4 

 It is understood and agreed that the Lead Arrangers will manage and control all aspects of the
solicitation of the Required Approvals or, if applicable, the syndication in consultation with you, including decisions as to the selection of prospective Lenders (which selection shall, for the avoidance of doubt, be subject to your consent (not to
be unreasonably withheld or delayed)), when commitments will be accepted, and final allocations of the commitments among the Lenders. You agree that no other agents, co-agents, arrangers, syndication agents or book managers or bookrunners will be
appointed, no other titles will be awarded and no compensation (other than that expressly contemplated by the Fee Letter) will be paid in connection with the solicitation of the Required Approvals or, if applicable, the New Revolving Credit Facility
unless otherwise agreed between the Commitment Parties and you. It is also understood and agreed that the amount and distribution of the fees among the Lenders will be at the sole and absolute discretion of the Lead Arrangers. You and we also agree
that BNP Paribas will have “left” placement and Scotiabank will appear to its immediate right in any and all marketing materials or other documentation used in connection with the New Revolving Credit Facility. 

Notwithstanding any other provision of this Commitment Letter to the contrary and notwithstanding any syndication, assignment or other
transfer by the Initial Lenders, (a) the Initial Lenders shall not be relieved, released or novated from its obligations hereunder (including its obligation to fund its applicable percentage of the New Revolving Credit Facility on the Funding
Date) in connection with any syndication, assignment or other transfer until after the funding of the New Revolving Credit Facility on the Funding Date, (b) no such syndication, assignment or other transfer shall become effective with respect
to any portion of the Initial Lenders’ commitments in respect of the New Revolving Credit Facility until the funding of the New Revolving Credit Facility on the Funding Date, and (c) unless the Company agrees in writing, the Initial
Lenders shall retain exclusive control over all rights and obligations with respect to its commitments in respect of the New Revolving Credit Facility, including all rights with respect to consents, waivers, modifications, supplements and
amendments, until the Funding Date has occurred. 
 The Commitment Parties hereby acknowledge and agree that the syndication described in
this Section 2 is not a condition to the obligation of the Initial Lenders to fund the New Revolving Credit Facility. 
 3.
Information. 
 You hereby represent, warrant that (with respect to information provided by or relating to the Acquired Business or
its respective operations or assets, to your knowledge) (a) all written factual information and written factual data, other than (i) the Projections (defined below), estimates, budgets and other forward-looking information and
(ii) information of a general economic or industry specific nature (such written information and data other than as described in the immediately preceding clauses (i) and (ii), the “Information”), that has been or
will be made available to the Lead Arrangers or the other Lenders, directly or indirectly, by you, the sellers of the Acquired Business, the Acquired Business or by any of your or their respective representatives on your behalf in connection with
the transactions contemplated hereby, when taken as a whole after giving effect to all supplements and updates provided thereto, is or will be, when furnished, supplemented or updated, correct in all material respects and does not or will not, when
furnished, supplemented or updated, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such
statements are made (after giving effect to all supplements and updates provided thereto through the later of the Closing Date and the Syndication Date) and (b) the Projections, when taken as a whole, have been, or will be, prepared in good
faith based upon 

  
 5 

 
assumptions that are believed by you to be reasonable at the time prepared and at the time the related Projections are so furnished; it being understood that (i) the Projections are merely a
prediction as to future events and are not to be viewed as facts, (ii) the Projections are subject to significant uncertainties and contingencies, many of which are beyond the control of you and/or the Acquired Business, and (iii) no
assurance can be given that any particular Projections will be realized and that actual results during the period or periods covered by any such Projections may differ significantly from the projected results and such differences may be material.
You agree that if, at any time prior to the later of the Syndication Date and the Closing Date, you become aware that any of the representations in the preceding sentence would be incorrect in any material respect if the Information or the
Projections were being furnished and such representations were being made at such time, you will (or, with respect to Information and Projections concerning the Acquired Business, you will, subject to any applicable limitations on your rights as set
forth in the Acquisition Agreement, use commercially reasonable efforts to) supplement the Information and the Projections from time to time until such later date such that (to your knowledge with respect to the Acquired Business and its
subsidiaries) the representations and warranties will be correct under those circumstances, it being understood that such supplementation (to the extent made prior to the Closing Date) shall cure any breach of such representation and warranty. You
understand that in arranging and syndicating the New Revolving Credit Facility, the Lead Arrangers will be using and relying on the Information and the Projections without independent verification thereof. 

The Commitment Parties hereby acknowledge and agree that the requirement to provide the information described in this Section 3 is not a
condition to the obligation of the Initial Lenders to fund the New Revolving Credit Facility. 
 4. Expenses; Indemnification. 

Whether or not a definitive financing agreement is entered into, you shall pay (or cause to be paid) our reasonable out-of-pocket costs and
expenses (including the reasonable fees and expenses of one primary law firm and one local counsel for each of BNP Paribas and Scotiabank in each reasonably necessary, relevant and material jurisdiction, professional fees of consultants and other
experts, and syndication and due diligence expenses) incurred before or after the date of this Commitment Letter arising in connection with the Commitment Letter, the Fee Letter, the definitive documentation for the Amendment or New Revolving Credit
Facility, the solicitation of the Required Approvals, the syndication of the New Revolving Credit Facility and the other transactions contemplated hereby, whether or not the Amendment or New Revolving Credit Facility closes; provided that you shall
not be required to pay our legal expenses relating to enforcement of the Company’s rights under this Commitment Letter or the Fee Letter. 

You hereby agree to indemnify and hold harmless the Administrative Agent, the Commitment Parties and their respective affiliates and each
director, officer, employee, agent, attorney and affiliate thereof (each such person, an “Indemnified Person”) from and against any losses, claims, damages, liabilities or other expenses to which an Indemnified Person may
become subject, insofar as such losses, claims, damages, liabilities (or actions or other proceedings commenced or threatened in respect thereof) or other expenses arise out of or in any way relate to or result from the Transaction, the solicitation
of the Required Approvals, this Commitment Letter and the Fee Letter or any other transaction contemplated by the foregoing, and to reimburse, on demand, each Indemnified Person for any reasonable legal or other expenses of one primary law firm and
one local counsel (and, in the case of an actual conflict of interest, one additional counsel to the affected Indemnified Persons) in each reasonably necessary, relevant and material jurisdiction, or other reasonable and documented out-of-pocket
expenses incurred in connection with investigating, defending or participating in any such investigation, litigation or other proceeding (a “Proceeding”) (whether or not any such investigation, litigation or other proceeding
involves claims made among you, the Acquired Business, its subsidiaries or any third party (other than any Indemnified 

  
 6 

 
Person), on the one hand, and any such Indemnified Person, on the other hand, and whether or not any such Indemnified Person is a party to any Proceeding out of which any such expenses arise);
provided, the indemnity contained herein shall not apply to the extent that it is determined in a final nonappealable judgment by a court of competent jurisdiction that such losses, claims, damages, liabilities or other expenses result from
(a) the bad faith, gross negligence or willful misconduct of any Indemnified Person or any material breach of any Indemnified Person’s obligations hereunder, (b) the material breach of any Indemnified Person’s obligations under
this Commitment Letter, or (c) disputes arising solely among Indemnified Persons, other than (x) disputes involving BNP Paribas or Scotiabank solely in each of their respective capacities as administrative agent, amendment arranger,
book-runner or lead arranger (as applicable) for the Amendment or, if applicable, the New Revolving Credit Facility but solely with respect to BNP Paribas or Scotiabank in such capacity and not to any other Indemnified Person, person or entity
involved therewith and (y) claims not arising out of any act or omission of you, the Acquired Business or any of your or their respective subsidiaries or affiliates. You shall not be liable for any settlement of any Proceeding (or expenses
solely in respect of such settlement) effected without your consent (which consent shall not be unreasonably withheld, delayed or conditioned but in any event not be required during an event of default under the Existing Revolving Credit Agreement
or, if applicable, the Credit Documents), but if settled with your written consent (if required), or if there is a final judgment against an Indemnified Person in any such Proceeding, you agree to indemnify and hold harmless each Indemnified Person
to the extent and in the manner set forth above. You shall not, without the prior written consent of the affected Indemnified Person (which consent shall not be unreasonably withheld or delayed), effect any settlement of any pending or threatened
Proceeding against such Indemnified Person in respect of which indemnity could have been sought hereunder by such Indemnified Person unless such settlement (x) includes an unconditional release of such Indemnified Person from all liability or
claims that are the subject matter of such Proceeding and (y) does not include any statement as to any admission of fault or culpability. The obligations to indemnify each Indemnified Person and to pay such legal and other expenses shall remain
effective until the Closing Date, and thereafter the indemnification and expense reimbursement obligations contained herein shall automatically terminate and be superseded by those contained in the definitive documentation for the Amendment or, if
applicable, the New Revolving Credit Facility pursuant to which the Company shall be liable for such indemnification and expense reimbursement obligations as provided therein. No party hereto shall be liable for any damages arising from the use by
others of the Information or other materials obtained through internet, DebtDomain, SyndTrak, IntraLinks or similar information transmission systems in connection with the solicitation of the Required Approvals, the Amendment or the New Revolving
Credit Facility, except to the extent any such damages are found in a final non-appealable judgment of a court of competent jurisdiction to have resulted from the gross negligence, bad faith or willful misconduct of, or material breach of this
Commitment Letter or the Fee Letter by, such person (or its controlled affiliates and controlling persons and their respective directors, officers, employees, partners, advisors, agents and other representatives); provided, nothing contained
in this sentence shall limit your indemnification and reimbursement obligations to the extent expressly set forth herein. No Indemnified Person or any indemnifying person shall be responsible or liable to any other party or any other person for any
indirect, consequential, punitive or special damages in connection with the Transaction, the solicitation of the Required Approvals, the New Revolving Credit Facility, this Commitment Letter, the Fee Letter or any other transaction contemplated by
the foregoing. The foregoing provisions of this paragraph shall be in addition to any rights that any Indemnified Person may have at common law or otherwise. 

5. Marketing Period. 
 You
will afford us a marketing period of at least 20 consecutive business days (the “Marketing Period”) following the earlier of (x) launch of the general syndication of the Term Loan Facility (which launch will be deemed to
occur on the date of the initial meeting (including telephonically) of the prospective Lenders) and (y) the delivery by the Borrower to the Lead Arrangers of the Required Information. “Required Information” will mean the
materials required to be delivered pursuant to clauses (a) and (b) in paragraph 2 hereof. 

  
 7 

 The Commitment Parties hereby acknowledge and agree that the Marketing Period described in this
Section 5 is not a condition to the obligation of the Initial Lenders to fund the New Revolving Credit Facility. 
 6.
Confidentiality and Sharing Information. 
 This Commitment Letter is delivered to you on the understanding that neither this
Commitment Letter nor the Fee Letter nor any of their terms or substance shall be disclosed, directly or indirectly, by you to any other person or entity except (a) to your affiliates officers, directors, employees, attorneys, accountants and
advisors who are directly involved in the consideration of this matter and on a confidential and need-to-know basis, (b) as required by applicable law or compulsory legal process or in connection with any pending legal proceeding or regulatory
review (in each case under this clause (b), you agree, to the extent permitted by applicable law, to inform us promptly thereof) or (c) to the extent that such information becomes publicly available other than by reason of improper disclosure
by you; provided that you may disclose this Commitment Letter and the Fee Letter (but as to the Fee Letter, only to the extent the Fee Letter has been redacted to delete all of the economic provisions thereof) (i) to the Acquired
Business, its affiliates and their respective officers, directors, employees, attorneys, accountants, agents and advisors, in each case who are directly involved in the consideration of this matter and on a confidential and need-to-know basis,
(ii) to any rating agencies, (iii) to actual or prospective counterparties (or their advisors) to any swap or derivative transaction relating to you or any of your affiliates or any of their respective obligations, (iv) after your
acceptance of this Commitment Letter and the Fee Letter, in required filings with the Securities and Exchange Commission and other applicable regulatory authorities and stock exchanges, (v) in connection with any action or proceeding relating
to this Commitment Letter, the Fee Letter or the transactions contemplated hereby or the enforcement of any rights hereunder or thereunder and (vi) as we may permit in writing. 

We agree to hold all non-public information regarding you, the Acquired Business, your and its affiliates and business, identified as such by
you and obtained by us in connection with the transactions contemplated hereby, in accordance with our respective customary procedures for handling confidential information of such nature, it being understood and agreed by you that, in any event, we
(a) may make disclosures of such non-public information (i) to our affiliates and to our and our affiliates’ respective employees, legal counsel, independent auditors and other experts or agents and advisors or to our current or
prospective financing sources and to other persons authorized by any of us to organize, present or disseminate such information in connection with disclosures otherwise made in accordance with this paragraph 6 (it being understood that the persons
to whom such disclosure is made will be informed of the confidential nature of such information and instructed to keep such information confidential), (ii) to any actual or potential assignee, transferee, participant or securitization party of
any rights, benefits, interests and/or obligations arising out of the New Revolving Credit Facility or to any direct or indirect contractual counterparties (or the professional advisors thereto) in swap or derivative transactions related to the New
Revolving Credit Facility (it being understood that the persons to whom such disclosure is made will be informed of the confidential nature of such information and instructed to keep such information confidential), (iii) to (x) any rating
agency in connection with rating you, your subsidiaries or the New Revolving Credit Facility or (y) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers with respect to the New Revolving
Credit Facility, (iv) as required or requested by any regulatory authority purporting to have jurisdiction over any of us or any of our respective affiliates (including any self-regulatory authority, such as the National Association of
Insurance Commissioners) (in which case the applicable Commitment Party shall, except with respect to any audit or examination conducted by bank accountants or any governmental bank regulatory 

  
 8 

 
authority exercising examination or regulatory authority, promptly notify you, in advance, to the extent lawfully permitted to do so), (v) to the extent required by order of any court,
governmental agency or representative thereof or in any pending legal or administrative proceeding, or otherwise as required by applicable law or judicial process (in which case, to the extent permitted by law, the applicable Commitment Party agrees
to inform you promptly thereof), (vi) in connection with any action or proceeding relating to this Commitment Letter, the Fee Letter or the transactions contemplated hereby or the enforcement of any rights hereunder or thereunder,
(vii) for purposes of establishing a “due diligence” defense, (viii) with the consent of you, or (ix) to the extent such information (x) becomes publicly available other than as a result of a breach of this paragraph 6,
(y) becomes available to us or any of our respective affiliates on a non-confidential basis from a source other than you, the Acquired Business, or your or their respective affiliates, or (z) is independently developed by us or any of our
respective affiliates; (b) after the closing of the Transaction, may disclose the existence of the Amendment, or in the event of an Amendment Failure, the Credit Documents and the information about such Amendment or Credit Documents to market
data collectors and similar services providers to the lending industry (including without limitation for league table designation purposes) and to service providers to us or any of our respective affiliates in connection with the administration and
management of such Amendment or Credit Documents; and (c) after the closing of the Transaction, we may (at our own expense) place advertisements in financial and other newspapers and periodicals or on a home page or similar place for
dissemination of information on the Internet or worldwide web as we may choose, and circulate similar promotional materials, in the form of a “tombstone” or otherwise describing the names of you and your affiliates (or any of them), and
the amount, type and closing date with respect to the transactions contemplated hereby. Our respective obligations under this paragraph shall automatically terminate and be superseded by the confidentiality provisions contained in the definitive
documentation for the Amendment or, in the event of an Amendment Failure, the definitive documentation for the New Revolving Credit Facility upon the initial funding of the New Revolving Credit Facility. 

You agree, on behalf of yourself and your affiliates, that all information (including but not limited to the Projections) provided by or on behalf of you and
your affiliates to us in connection with soliciting the Required Approvals or the New Revolving Credit Facility may be disseminated by or on behalf of us and made available to prospective Lenders who have agreed to be bound by customary
confidentiality undertakings (including, “click-through” agreements), all in accordance with our and our respective affiliates’ standard loan syndication practices (whether transmitted electronically by means of a website, e-mail or
otherwise, or made available orally or in writing, including at prospective Lender or other meetings). You hereby further authorize us to download copies of your and the Acquired Business’ logos from their respective websites and post copies
thereof on a DebtDomain, SyndTrak, IntraLinks or similar workspace and use such logos on any confidential information memoranda, presentations and other marketing materials. 

7. Absence of Fiduciary Relationship; Affiliate Activities. 

You acknowledge that any Commitment Party or its affiliates may be providing financing or other services to parties whose interests may
conflict with yours. You further acknowledge and agree that (a) no fiduciary, advisory or agency relationship between you and us or any of our respective affiliates is intended to be or has been created in respect of any of the transactions
contemplated by this Commitment Letter, irrespective of whether we or any of our respective affiliates has advised or is advising you on other matters, (b) the Commitment Parties, on the one hand, and you, on the other hand, have an arms-length
business relationship that does not directly or indirectly give rise to, nor do you rely on, any fiduciary duty on the part of any Commitment Party, (c) you are capable of evaluating and understanding, and you understand and accept, the terms,
risks and conditions of the transactions contemplated by the Commitment Letter, (d) you have been advised that each Commitment Party is engaged in a broad range of transactions that may involve interests that differ from your interests and that
none of the Commitment 

  
 9 

 
Parties has any obligation to disclose such interests and transactions to you by virtue of any fiduciary, advisory or agency relationship, and (e) you waive, to the fullest extent permitted
by law, any claims you may have against any Commitment Party for breach of fiduciary duty or alleged breach of fiduciary duty and agree that none of the Commitment Parties shall have any liability (whether direct or indirect) to you in respect of
such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of you, including your stockholders, employees or creditors. Additionally, you acknowledge and agree that none of the Commitment Parties is
advising you as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. You shall consult with your own advisors concerning such matters and shall be responsible for making your own independent investigation and
appraisal of the transactions contemplated hereby, and none of the Commitment Parties shall have any responsibility or liability to you with respect thereto. Any review by any Commitment Party of the Company, the Acquired Business, the Transaction,
the other transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of such Commitment Party and shall not be on behalf of you or any of your affiliates. 

8. PATRIOT Act Notification. 

We hereby notify you that pursuant to the requirements of the USA PATRIOT Improvement and Reauthorization Act, Title III of Pub. L. 109-177
(signed into law March 9, 2009) (as amended from time to time, the “PATRIOT Act”), each of us and each of the Lenders may be required to obtain, verify and record information that identifies the Company and any other
borrowers under the New Revolving Credit Facility, which information includes the name, address, tax identification number and other information regarding the Company and such other borrowers that will allow us and the Lenders to identify the
Company and such other borrowers in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act and is effective as to us and each Lender. 

9. Governing Law; Submission to Jurisdiction; Waiver of Jury Trial. 

This Commitment Letter and the Fee Letter shall be governed by, and construed in accordance with, the laws of the State of New York. Each of
the parties hereto expressly agrees that the state or federal courts located in New York County, State of New York shall have exclusive jurisdiction to hear and determine any claims pertaining to this Commitment Letter and the Fee Letter or any
transaction relating hereto, any other financing related thereto, and any investigation, litigation or proceeding related to or arising out of any such matter and hereby submits and consents in advance to such jurisdiction in any action or suit
commenced in any such court, and hereby waives any objection which any of them may have based on lack of personal jurisdiction, improper venue or inconvenient forum, provided, that, notwithstanding the preceding sentence and the governing law
provisions of this Commitment Letter and the Fee Letter, it is understood and agreed that (a) the interpretation of the definition of “Company Material Adverse Effect” and whether there shall have occurred a “Company Material
Adverse Effect,” (b) whether the Acquisition has been consummated in accordance with the terms of the Acquisition Agreement (as defined in Annex C) and (c) whether the Specified Acquisition Agreement Representations (as defined in
Annex C) are true and correct in all material respects as of the Funding Date (or, with respect to such representations that are qualified by materiality, material adverse effect or language of similar effect are true and correct in all respects as
of the Funding Date) and whether the Company has the right to terminate its obligations, or decline to consummate the Acquisition, under the Acquisition Agreement as a result of such representations and warranties failing to be true and correct,
shall be determined in accordance with the laws of the State of Delaware without regard to conflict of laws principles that may be applicable under conflicts of laws principles (whether of the State of Delaware or any other jurisdiction). Each of
the parties hereto irrevocably waives any and all right to trial by jury in any action, proceeding or counterclaim (whether based on contract, tort or otherwise) arising out of or relating to this Commitment Letter, the Fee Letter, the Transaction
and the other transactions contemplated hereby and thereby or the actions of any Commitment Party in the negotiation, performance or enforcement hereof or thereof. 

  
 10 

 10. Surviving Provisions. 

Paragraphs 5-10 hereof shall (except as otherwise therein provided) remain in full force and effect regardless of whether the definitive
documentation with respect to the Amendment or the Credit Documents are executed and delivered and notwithstanding the termination of this Commitment Letter or any commitment or undertaking of the Commitment Parties hereunder. In addition, in the
event the Credit Documents are executed and delivered, the provisions in paragraph 2 hereof shall survive until the Syndication Date. 
 11.
Assignment; Amendments; Counterparts; Etc. 
 This Commitment Letter is not assignable by you (other than to affiliates reasonably
acceptable to the Commitment Parties in connection with the structuring of the Transaction) without our prior written consent and is intended to be solely for the benefit of the parties hereto and each Indemnified Person. Any and all obligations of,
and services to be provided by, the Commitment Parties hereunder may be performed and any and all rights of the Commitment Parties hereunder may be exercised by or through any of its affiliates or branches. This Commitment Letter and the Fee Letter
may not be amended or waived except by an instrument in writing signed by the Commitment Parties and you. This Commitment Letter and the Fee Letter may be executed in counterparts which, when taken together, shall constitute one original. Delivery
of an executed counterpart of this Commitment Letter or the Fee Letter by telecopier, facsimile or electronic format (i.e., “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart thereof. 

This Commitment Letter, together with the Fee Letter, embodies the entire agreement and understanding among us, you and your affiliates with
respect to the New Revolving Credit Facility and supersedes all prior agreements and understandings, whether written or oral, relating to the specific matters hereof. Matters that are not covered or made clear in this Commitment Letter or in the Fee
Letter are subject to mutual agreement of the parties hereto. No party has been authorized by any Commitment Party to make any oral or written statements that are inconsistent with this Commitment Letter. 

12. Acceptance and Termination. 

This Commitment Letter and all commitments and undertakings of the Commitment Parties hereunder will expire automatically and without further
action or notice and without further obligation to you at 5:00 p.m. (New York City time) on August 1, 2017 unless you execute this Commitment Letter and the Fee Letter and return them prior to that time to (i) BNP Paribas at 787 Seventh
Avenue, New York, New York 10019, Attention: Brendan Heneghan and (ii) Scotiabank at 250 Vesey Street, New York, New York 10281, Attention: Michael Grad. Thereafter, all commitments and undertakings of the Commitment Parties hereunder will
expire on the earliest to occur of (a) August 1, 2018, unless the Closing Date occurs on or prior thereto, (b) any time after the execution of the Acquisition Agreement and prior to the consummation of the Transaction, the date of the
termination of the Acquisition Agreement (other than with respect to ongoing indemnities, confidentiality provisions and similar provisions), and (c) the closing of the Acquisition without the receipt of the Required Approvals or the use of the
New Revolving Credit Facility. 
 [remainder of page intentionally left blank] 

  
 11 

 We are pleased to have the opportunity to work with you in connection with this important
financing. 
  

			
	Sincerely yours,
	
	BNP PARIBAS SECURITIES CORP.
		
	By:	 	 /s/ Brendan Heneghan

		 	Name: Brendan Heneghan
		 	Title: Director
		
	By:	 	 /s/ Karim Remtoula

		 	Name: Karim Remtoula
		 	Title: Vice President
	
	BNP PARIBAS
		
	By:	 	 /s/ Brendan Heneghan

		 	Name: Brendan Heneghan
		 	Title: Director
		
	By:	 	 /s/ Karim Remtoula

		 	Name: Karim Remtoula
		 	Title: Vice President

 [Signature page to Commitment Letter] 

 
			
	THE BANK OF NOVA SCOTIA
		
	By:	 	 /s/ Michael Grad

		 	Name: Michael Grad
		 	Title: Director

  
 [Signature page to
Commitment Letter] 

			
	Agreed and Accepted
	this 1st day of August, 2017
	
	JACOBS ENGINEERING GROUP INC.
		
	By:	 	 /s/ Kevin C. Berryman

		 	Name: Kevin C. Berryman
		 	Title: Executive Vice President and Chief Financial Officer

  
 [Signature page to
Commitment Letter] 

 SCHEDULE I 

Commitments 
  

					
	 Initial Lenders
	  	Commitments	 
	 BNP Paribas
	  	$	800,000,000	 
	 The Bank of Nova Scotia
	  	$	800,000,000	 
	 Total
	  	$	1,600,000,000	 

 Execution Copy 

Annex A 
 JACOBS
ENGINEERING GROUP INC. 
 $1,600,000,000 Senior Unsecured Revolving Credit Facility 

Summary of Terms and Conditions 
 This
Summary of Terms and Conditions describes the principal terms of the New Revolving Credit Facility referred to in the Commitment Letter of which this Annex A is a part. All capitalized terms used but not defined herein have the meanings given to
them in the Commitment Letter. 
  

			
	Borrower:	  	Jacobs Engineering Group Inc. (the “Company”) and certain subsidiaries of the Company (each a “Designated Borrower” and, together with the Company, the
“Borrowers” and each, a “Borrower”).
		
	Joint Lead Arrangers and Joint Bookrunners:	  	BNP Paribas Securities Corp (“BNPPSC”) and The Bank of Nova Scotia (“Scotiabank”), in their capacities as Joint Lead Arrangers and Joint Bookrunners (collectively, the
“Lead Arrangers”).
		
	Administrative Agent:	  	BNP Paribas (“BNPP”) in its capacity as administrative agent (the “Administrative Agent”).
		
	Syndication Agent:	  	To be determined.
		
	Documentation Agent:	  	To be determined.
		
	Lenders:	  	Such banks, financial institutions and other lenders (including BNPP and Scotiabank, collectively, the “Lenders”) selected by the Lead Arrangers.
		
	Transaction:	  	The acquisition (the “Acquisition”) of “Project Charlotte” and its subsidiaries (the “Acquired Business”), the Term Loan Facility, the Amendment or, if the Required
Approvals are not obtained, the New Revolving Credit Facility, the repayment of certain existing indebtedness of the Acquired Business, and the payment of all related fees and expenses (collectively, the
“Transaction”).
		
	Closing Date:	  	The date on which all conditions listed on the Conditions to Closing Schedule have occurred (the “Closing Date”).
		
	Funding Date:	  	The date on which the Acquisition is consummated and the initial funding of the New Revolving Credit Facility has occurred (the “Funding Date”), but in any event no later than August 1, 2018 (the
“Outside Date”).
		
	Revolving Credit Facility:	  	$1,600,000,000 senior unsecured revolving credit facility (the “New Revolving Credit Facility”, and the commitments under the New Revolving Credit Facility are referred to herein as the
“Commitments”, and the loans thereunder, together with (unless the context otherwise requires) the Swing Line Loans (as defined below), the “New Revolving Loans”).

  
 A-1 

			
		
		  	 The New Revolving Credit Facility will include a $1,055,000,000 multicurrency tranche (“Tranche 1”, and the
commitments under Tranche 1 are referred to herein as the “Tranche 1 Commitments” and the loans thereunder, the “Tranche 1 Loans) and (ii) a $545,000,000 multicurrency tranche (“Tranche
2”, and the commitments under Tranche 2 are referred to herein as the “Tranche 2 Commitments” and the loans thereunder, the “Tranche 2 Loans).

 
 A portion of the Tranche 1 Commitments, in amounts and on terms substantially consistent
with the Existing Revolving Credit Agreement, will be made available to certain of the Borrowers by the Administrative Agent (in such capacity, the “Swing Line Lender”) as swing line loans (the “Swing Line
Loans”).
  
 A portion of the Tranche 1 Commitments, in amounts and on terms
substantially consistent with the Existing Revolving Credit Agreement, will be made available to certain of the Borrowers by the Administrative Agent (and each other consenting Lender that is acceptable to the Company and the Administrative Agent
(each, an “Issuing Lender”)) for the issuance of letters of credit (“Letters of Credit”).

		
	 Increase in Commitments:
	  	The New Revolving Credit Facility will permit the Borrowers to increase Commitments under the New Revolving Credit Facility in amounts and on terms substantially consistent with the Existing Revolving Credit Agreement.
		
	 Credit Documents:
	  	The definitive financing documentation for the New Revolving Credit Facility (the “Credit Documents”) will contain conditions to borrowing, representations, warranties, financial, affirmative and negative
covenants and events of default, in each case, with customary exceptions, qualifications, baskets, grace periods and thresholds to be mutually agreed, as set forth in this Term Sheet and as are usual and customary for financings of this kind and
such other terms as may be mutually agreed; it being understood and agreed that the terms and conditions of the Credit Documents will be substantially consistent with the terms and conditions of the Existing Revolving Credit Agreement, as modified
to incorporate the Required Approvals (the “Amended Revolving Credit Agreement”).
		
	 Purpose/Use of Proceeds:
	  	Proceeds will be used to fund the Transaction, including to refinance all amounts outstanding under the Existing Revolving Credit Agreement.
		
	 Availability:
	  	Amounts available under the New Revolving Credit Facility may be borrowed, repaid and reborrowed on and after the Funding Date until the maturity date. If the New Revolving Loans have not been funded on or prior to the earlier of
(a) the date of termination of the Acquisition Agreement in accordance with its terms and (b) the Outside Date (such earlier date, the “Termination Date”), the New Revolving Credit Facility shall be permanently
cancelled.

  
 A-2 

			
		
	Maturity:	  	Same as the revolving credit commitments under the Existing Revolving Credit Agreement.
		
	Guarantees:	  	Substantially consistent to the guarantees under the Existing Revolving Credit Agreement.
		
	Interest Rate:	  	 At the Borrowers’ option, the New Revolving Loans will bear interest as follows:

 
 •    Adjusted Eurodollar
Rate plus the Applicable Margin, or
  

•    Base Rate plus the Applicable Margin.

 
 As used herein, the terms “Adjusted Eurodollar Rate” and “Base Rate”
will have meanings customary and appropriate for financings of this type (including with respect to statutory reserve requirements), and the basis for calculating accrued interest and the interest periods for New Revolving Loans bearing interest
based upon the Adjusted Eurodollar Rate (“Eurodollar Loans”) will be customary and appropriate for financings of this type; provided, that the Adjusted Eurodollar Rate shall be no less than zero. In no event will New
Revolving Loans bearing interest based upon the Base Rate (“Base Rate Loans”) be less than the sum of (a) the one-month Adjusted Eurodollar Rate (after giving effect to any
“floor”) plus (b) the difference between the applicable stated margin for Eurodollar Loans and the applicable stated margin for Base Rate Loans. Each Swing Line Loan will be outstanding only as a Base Rate Loan.

 
 As used herein, the term “Applicable Margin”, means the following percentage
per annum, based upon the following Consolidated Leverage Ratio level:

  

									
	 Consolidated Leverage Ratio
	  	Eurodollar Loans	 	 	Base Rate Loans	 
	 £ 1.25:1.00
	  	 	1.000	% 	 	 	0.000	% 
	 > 1.25:1.00 but < 1.75:1.00
	  	 	1.250	% 	 	 	0.250	% 
	 3 1.75:1.00 but <
2.25:1.00
	  	 	1.375	% 	 	 	0.375	% 
	 3 2.25:1.00
	  	 	1.500	% 	 	 	0.500	% 

  

			
		  	After the occurrence and during the continuance of a payment or bankruptcy event of default, interest on all amounts then outstanding will accrue at the following rates: (a) with respect to obligations other than Tranche 2
Loans and Letter of Credit Fees, (x) the Base Rate plus (y) the Applicable Margin, if any, applicable to Base Rate Loans (iii)

  
 A-3 

			
		  	 plus an additional two percentage points (2.00%) per annum, provided, however, that with respect to Eurodollar Loans,
the default rate shall be an otherwise applicable rate plus 2% per annum. (b) with respect to the Tranche 2 Loans, (x) the otherwise applicable rate (or if no such rate, then by reference to the Base Rate) plus
(y) an additional two percentage points (2.00%) per annum and (c) with respect to Letter of Credit Fees, a rate equal to (x) the Applicable Margin plus (y) an additional two percentage points (2.00%)
per annum.
  
 For purposes of determining the Applicable Margin described above
and Fees described below, Consolidated Leverage Ratio, Consolidated Net Income and Consolidated EBITDA will be defined in a manner substantially consistent with the Existing Revolving Credit Agreement (without giving effect to any amendments or
modification to the definitions of Consolidated Net Income or Consolidated EBITDA as described herein).

		
	Interest Payments:	  	Quarterly for Base Rate Loans; except as set forth below, on the last day of selected interest periods (which will be one, two, three and six months (or, if available, twelve months, with the consent of all affected Lenders), for
Eurodollar Loans (and at the end of every three months, in the case of interest periods longer than three months); and upon prepayment (to the extent accrued on the amount being prepaid), in each case payable in arrears and computed on the basis of
a 360-day year (365/366 day year with respect to Base Rate Loans).
		
	Fee:	  	 Commitment Fees: Payable to the Lenders under the New Revolving Credit Facility equal to (x) 0.100% per annum,
times (y) the daily average undrawn portion of the New Revolving Credit Facility (reduced by the amount of Letters of Credit issued and outstanding), with step- ups to (i) 0.150% per annum based on a Consolidated Leverage
Ratio of greater than 1.25:1.00, but less than 1.75:1.00, (ii) 0.200% per annum based on a Consolidated Leverage Ratio of equal to or greater than 1.75:1.00, but less than 2.25:1.00 and (iii) 0.250% per annum based on a Consolidated
Leverage Ratio of greater than 2.25:1.00.
  
 Letter of Credit Fees: Payable to
Lenders under the New Revolving Credit Facility equal to (a) in the case of Financial Credits (as defined in the Existing Revolving Credit Agreement): (x) the applicable margin then in effect for Eurodollar Loans under the Revolving Facility,
times (y) the daily average maximum amount available under all issued and undrawn Letters of Credit and (b) in the case of Performance Credits (as defined in the Existing Revolving Credit Agreement): (x) 0.625% per
annum, times (y) the daily average maximum amount available under all issued and undrawn Letters of Credit, with step-ups to (i) 0.750% per annum based on a Consolidated
Leverage Ratio of greater than 1.25:1.00, but less than 1.75:1.00, (ii) 0.875% per annum based on a Consolidated Leverage Ratio of equal to or greater than 1.75:1.00, but less than 2.25:1.00, and (iii) 1.000% per annum based on a
Consolidated Leverage Ratio of greater than 2.25:1.00.

  
 A-4 

			
		  	 Each of the foregoing fees will be computed on the basis of a 360-day year and actual days elapsed
and will accrue and be payable quarterly in arrears.
  
 In addition, the Borrowers will
pay to each Issuing Lender certain other customary fees assessed with respect to each Letter of Credit issued thereby.

		
	Other Fees:	  	See separate confidential Fee Letter.
		
	Amortization:	  	Payable at maturity (no required amortization).
		
	Voluntary Prepayments:	  	Voluntary prepayments may be made subject to provisions substantially consistent with those under the Existing Revolving Credit Agreement.
		
	Representations and Warranties:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Financial Definitions:	  	See Annex D for the definitions of Consolidated Net Income and Consolidated EBITDA, solely for the purpose of testing compliance with the Consolidated Leverage Ratio and Consolidated Net Worth.
		
	Financial Covenants:	  	 Substantially consistent with the Existing Revolving Credit Agreement, except the level of the Consolidated Leverage Ratio test shall be
modified as follows:
  

a.      with respect to any fiscal quarter ending on or prior to the one year
anniversary of the Closing Date, 3.25:1.00; and
  

b.      thereafter, 3.00:1.00;

 
 provided that, at the request of the Company following a material Permitted
Acquisition (other than the Acquisition), such level shall be increased to 3.50:1.00 for a period of twelve months (“Elevated Compliance Period”); provided further, that the Consolidated Leverage
Ratio shall be brought within the 3.00:1:00 level required by the Consolidated Leverage Ratio test for one full fiscal quarter period prior to any subsequent Elevated Compliance Period.

		
	Affirmative Covenants:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Negative Covenants:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Events of Default:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Conditions Precedent to the Closing Date:	  	The conditions to the closing of the New Revolving Credit Facility on the Closing Date will be subject only to those conditions listed in the Conditions to Closing Schedule.
		
	Conditions Precedent to the Borrowings and Issuances on the Funding Date:	  	The conditions to the initial funding of the New Revolving Credit Facility and the issuances of any Letters of Credit on the Funding Date will be subject only to those conditions listed in the Conditions to Funding
Schedule.

  
 A-5 

			
		
	Conditions Precedent to Subsequent Borrowings and Issuances:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Assignments and Participations:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Amendments and Waivers:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Taxes; Yield Protection; “EU Bail-In”:	  	 The Credit Documents will provide that all payments are to be made free and clear of any taxes, imposts, assessments, withholdings or other
deductions whatsoever, subject in each case to customary exceptions.
  
 The Borrowers
will indemnify the Lenders against customary Eurodollar Rate breakage costs as well as all increased costs of capital resulting from reserve requirements or otherwise imposed, in each case subject to customary increased costs, capital adequacy and
similar provisions to the extent not taken into account in the calculation of the Base Rate or Adjusted Eurodollar Rate. The Credit Documents will include customary “EU Bail-In”
provisions.

		
	Non-Consenting and Defaulting Lenders:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Indemnity and Expenses:	  	Substantially consistent with the Existing Revolving Credit Agreement.
		
	Governing Law and Forum:	  	New York.
		
	Counsel to Lead Arrangers and Administrative Agent:	  	Winston & Strawn LLP.

  
 A-6 

 Annex B 

Schedule of Conditions Precedent to the New Revolving Credit Facility on the Closing Date 

This Schedule of Conditions Precedent to the New Revolving Credit Facility sets forth the conditions to closing the New Revolving Credit Facility on the
Closing Date and is the Conditions to Closing Schedule referred to in the Commitment Letter of which this Annex B is a part. Certain capitalized terms used herein are defined in the Commitment Letter, the Summary of Terms and Conditions attached
thereto as Annex A and the Conditions to Funding Schedule attached thereto as Annex C. 
  

	1.	Representations and Warranties. Each of the representations and warranties made by Borrowers set forth in the Credit Documents relating to (a) existence, qualification and power (as to the execution,
delivery and performance of the applicable Credit Documents); (b) authorization (as to the execution, delivery, and performance of the applicable Credit Documents); (c) binding effect and enforceability of the Credit Documents; (d) no conflicts
of the Credit Documents with charter documents or applicable law; (e) margin regulations and Investment Company Act, (f) use of proceeds not violating OFAC, PATRIOT ACT or FCPA; (g) solvency; (h) status of the New Revolving Credit
Facility as senior debt and (i) no payment, financial covenants (tested on a standalone (non-pro-forma) basis and without giving effect to the Acquisition or any
indebtedness incurred in connection with the Acquisition) or bankruptcy Event of Default (the “Specified Representations”) shall be true and correct in all material respects as of the Closing Date (provided any such
representations that are qualified by materiality, material adverse effect or language of similar effect shall be true and correct in all respects as of the Closing Date). 

 

	2.	Credit Documents. The Borrowers and all other relevant parties will have executed and delivered the applicable Credit Documents. 

 

	3.	Financial Information. The Lead Arrangers will have received (a) audited consolidated balance sheets and related statements of income, stockholders’ equity and cash flows of the Company as of the last
day of and for the three most recently completed fiscal years ended at least 90 days prior to the Closing Date, and the Lead Arrangers hereby acknowledge receipt of such financial statements for the 2016 fiscal year of the Company;
(b) unaudited consolidated balance sheets and related statements of income, stockholders’ equity and cash flows of the Company as of the last day of and for each subsequent fiscal quarter (other than the fourth fiscal quarter of the fiscal
year of the Acquired Business) ended at least 45 days prior to the Closing Date, and the Lead Arrangers hereby acknowledge receipt of such financial statements for the fiscal quarter ending on March 31, 2017; (c) pro forma balance sheet and
income statements of the Company as of and for the twelve-month period ending on the last day of the most recently completed four fiscal quarter period for which financial statements have been delivered pursuant to this paragraph, prepared after
giving effect to the Transaction as if the Transaction had occurred as of such date (in the case of the balance sheet) or at the beginning of such period (in the case of such statement of income); and (d) financial projections prepared by the
Company and its subsidiaries on an annual basis thereafter to and including 2017, 2018, 2019 and 2020, which financial projections are in form and substance reasonably satisfactory to the Lead Arrangers, and the Lead Arrangers hereby acknowledge
receipt of financial projections which satisfy the requirements of this paragraph 3(d). 

  

	4.	Fees and Expenses. All fees and expenses related to the Transaction payable to the Lead Arrangers, the Administrative Agent, the Lenders and third party service providers that are specifically required to be paid
on the Closing Date by the Term Sheet and under the Commitment Letter and the Fee Letter shall have been paid. 

  
 B-1 

	5.	Closing Deliverables. The Company will have delivered the following: (a) customary evidence of authorization of the Credit Documents; (b) customary officer’s certificates; (c) good standing
certificates (to the extent applicable) in the jurisdiction of organization of the Borrowers; (d) a customary solvency certificate on a consolidated basis from the chief financial officer of the Company; and (e) customary legal opinions.
So long as requested by the Administrative Agents at least ten business days prior to the Closing Date, the Administrative Agent will have received, no later than five business days prior to the Closing Date, all documentation and other information
reasonably necessary for reasonably satisfactory compliance with applicable know your customer and anti-money laundering rules and regulations and the PATRIOT Act. 

  
 B-2 

 Annex C 

Schedule of Conditions Precedent to the New Revolving Credit Facility on the Funding Date 

This Schedule of Conditions Precedent to the New Revolving Credit Facility sets forth the conditions to the initial availability and borrowing of the New
Revolving Credit Facility on the Funding Date and is the Conditions to Funding Schedule referred to in the Commitment Letter of which this Annex C is a part. Certain capitalized terms used herein are defined in the Commitment Letter, the Summary of
Terms and Conditions attached thereto as Annex A and the Conditions to Closing Schedule attached thereto as Annex B. 
  

	1.	Concurrent Transactions. Concurrent with or prior to the initial availability of and borrowing under New Revolving Credit Facility on the Funding Date, the following will occur: 

(a) The Company and each other party to the Term Loan Credit Facility shall have executed and delivered the Term Loan Credit
Facility Documentation on terms consistent with the Term Loan Facility Commitment Letter and otherwise reasonably satisfactory to the Commitment Parties.     

(b) The Acquisition will have been consummated in accordance with the terms of the Agreement and Plan of Merger dated as of the
date of the Commitment Letter, among the Company, the Charlotte entity specified therein and the other parties thereto (as amended, supplemented, or otherwise modified in accordance with this paragraph 2(b), the “Acquisition
Agreement”), which will be in form and substance reasonably satisfactory to the Lead Arrangers (and the Lead Arrangers hereby acknowledge that the Acquisition Agreement delivered to them as of August 1, 2017 is satisfactory), and
all conditions precedent for the Company to the consummation of the Acquisition, as set forth in the Acquisition Agreement, will have been satisfied in all material respects without any waiver, amendment, supplement or other modification that is
materially adverse to the Lenders unless the Lead Arrangers will have consented thereto; provided that (x) any change in the definition of “Company Material Adverse Effect” (as defined in the Acquisition Agreement) and
(y) any materially adverse modifications to any of the following provisions contained in Sections 7.3, 8.9, 8.12 and 8.15 of the Acquisition Agreement that relate to the Administrative Agent’s or any Lender’s liability, jurisdiction,
or status as a third party beneficiary under the Acquisition Agreement, in each case, shall be deemed to be materially adverse to the interest of the Lenders. 
  

	2.	Representations and Warranties. 

 (a) Each of the Specified
Representations shall be true and correct in all material respects as of the Funding Date (provided any such representations that are qualified by materiality, material adverse effect or language of similar effect shall be true and correct in all
respects as of the Funding Date). 
 (b) Each of the representations and warranties made by the Acquired Business in the
Acquisition Agreement as are material to the interests of the Lenders (the “Specified Acquisition Agreement Representations”) shall be true and correct in all material respects as of the Funding
Date (provided any such representations that are qualified by materiality, material adverse effect or language of similar effect shall be true and correct in all respects as of the Funding Date), but only to the extent that Company has the right to
terminate its obligations, or decline to consummate the Acquisition, under the Acquisition Agreement as a result of such representations and warranties failing to be true and correct. 

  
 C-1 

	3.	No Material Adverse Change. Since the date of the Acquisition Agreement, there has not occurred any change, event, development, condition, occurrence or effect or state of facts that has had a Company Material
Adverse Effect (as defined in the Acquisition Agreement). 

  

	4.	Financial Information. The Lead Arrangers will have received (a) audited consolidated balance sheets and related statements of income, stockholders’ equity and cash flows of the Acquired Business as of
the last day of and for the three most recently completed fiscal years ended at least 90 days prior to the Funding Date, and the Lead Arrangers hereby acknowledge receipt of such financial statements for the 2014, 2015, and 2016 fiscal years of the
Acquired Business; and (b) unaudited consolidated balance sheets and related statements of income, stockholders’ equity and cash flows of the Acquired Business as of the last day of and for each subsequent fiscal quarter (other than the fourth
fiscal quarter of the fiscal year of the Acquired Business) ended at least 45 days prior to the Funding Date, and the Lead Arrangers hereby acknowledge receipt of such financial statements for the fiscal quarter ending on March 31, 2017;

  

	5.	Fees and Expenses. All fees and expenses related to the Transaction payable to the Lead Arrangers, the Administrative Agent, the Lenders and third party service providers that are specifically required to be paid
on the Funding Date by the Term Sheet and under the Commitment Letter and the Fee Letter shall have been paid. 

  

	6.	Funding Deliverables. The Administrative Agent shall have received an executed notice of borrowing for the funding of the New Revolving Credit Facility and reasonably satisfactory confirmation of arrangements for
the repayment of and release of liens with respect to all existing third-party indebtedness for borrowed money of the Borrowers and the Acquired Business (except for Permitted Surviving Debt). 

 

	7.	Funding Date. The Funding Date will have occurred on or prior to the Termination Date.     

  
 C-2 

 Annex D 

Consolidated Net Income and Consolidated EBITDA Definitions 

“Consolidated Net Income” means, for any period, the consolidated net income of the Company and its 

Subsidiaries as determined in accordance with GAAP. 

“Consolidated EBITDA” means, for any period, an amount determined for the Company and its Subsidiaries on a consolidated basis equal to: 

(a) Consolidated Net Income for such period, plus, 
 (b)
the following to the extent deducted in calculating such Consolidated Net Income, the sum, without duplication, of amounts for: 
  

	 	i.	Consolidated Interest Charges, 

  

	 	ii.	the provision for Federal, state, local and foreign income taxes payable by the Company and its Subsidiaries, 

  

	 	iii.	depreciation and amortization, 

  

	 	iv.	any extraordinary, unusual, infrequent or non-recurring losses, 

  

	 	v.	any costs, charges, accruals, reserves or expenses attributable to the undertaking and/or implementation of cost savings, operating expense reductions, restructuring, severance, business optimization, integration,
transition, decommissioning, lease termination payments, consolidation and other restructuring costs, charges, accruals, reserves or expenses in an amount not to exceed (i) with respect to any four-fiscal quarter period the last day of which is
on or prior to the first anniversary of the consummation of the Charlotte Acquisition (x) $200,000,000 in the aggregate in respect of any such cash costs, charges, accruals, reserves or expenses attributable to Company and its Subsidiaries (other
than the Acquired Business) and (y) $200,000,000 in the aggregate in respect any such cash costs, charges, accruals, reserves or expenses attributable to the Acquired Business, and (ii) with respect to any four-fiscal quarter period the last
day of which is after the first anniversary of the consummation of the Charlotte Acquisition, the greater of (x) 10% of Consolidated EBITDA (calculated prior to giving effect to any adjustment pursuant to this clause) and (y) $100,000,000, in the
aggregate in respect any such cash costs, charges, accruals, reserves or expenses attributable to the Company and its Subsidiaries (including the Acquired Business), provided that, in calculating the amount of cash costs, charges, accruals, reserves
or expenses attributable to the Company and its Subsidiaries (including the Acquired Business) for purposes of this clause (b)(v)(ii), any amount of cash costs, charges, accruals, reserves or expenses attributable to the Company and its Subsidiaries
(including the Acquired Business) included pursuant to clause (b)(v)(i)(x) or (y) above during such four fiscal quarter period shall count towards the limit described in this clause (b)(v)(ii), 

 

	 	vi.	fees and expenses in connection with the Acquisition and the related transactions contemplated by the Acquisition Agreement (including fees and expenses related to the Amendment, the New Revolving Credit Facility and
the entry into the Term Loan Credit Agreement), 

  

	 	vii.	fees and expenses incurred during such period in connection with any proposed or actual equity issuance or any proposed or actual issuance or incurrence of any Indebtedness, or any proposed or actual Acquisitions,
Investments or Dispositions, including any financing fees and any merger and acquisition fees, 

  
 D-1 

	 	viii.	any losses during such period resulting from the sale or Disposition of any assets of, or the discontinuation of any operations of, in each case, the Company or any Subsidiary, 

 

	 	ix.	non-cash charges and expenses that are either (a) related to stock option awards or other equity compensation, (b) in connection with any Acquisition, Investment or
Disposition or (c) impairment charges, 

  

	 	x.	any other non-cash charges or expenses (provided, that any cash payment made with respect to any such non-cash charge shall be
subtracted in computing Consolidated EBITDA during the period in which such cash payment is made), and 

  

	 	xi.	any cash or non-cash charges related to project losses in an aggregate amount not to exceed $50,000,000 for the twelve month period following the consummation of the Charlotte
Acquisition, minus, 

 (c) without duplication and to the extent included in arriving at such Consolidated Net Income, any
extraordinary, unusual, infrequent or non-recurring gains for such period, 
 provided, however, that
if there has occurred a Permitted Acquisition, Investment or Disposition during the relevant period, Consolidated EBITDA shall be calculated, at the option of the Company, on a pro forma basis after giving effect to such Permitted Acquisition,
Investment or Disposition as if such Permitted Acquisition, Investment or Disposition occurred on the first day of such period, and 
 provided,
further, that Consolidated EBITDA may, at the option of the Company, be further adjusted for any pro forma adjustments that are made in accordance with the SEC pro forma reporting rules under the Securities Exchange Act of 1934. 

  
 D-2EX-10.1

 Exhibit 10.1 

 
 

 
  

 PRIVATE AND CONFIDENTIAL 

Mr. Dirk Van de Put 
 July 27, 2017 

OFFER LETTER 
 Dear Dirk, 

I am very pleased to provide you with this offer letter setting forth the terms of your offer of employment (“Offer Letter”). It confirms the verbal
offer previously extended to you for the position of Chief Executive Officer of Mondelēz International, Inc. (the “Company”) reporting to the Company’s Board of Directors (“Board”) and to serve as a member of the Board
beginning coincident with your Start Date (as defined below) and, beginning April 1, 2018, also serve as Chairman of the Board. This position will be located in our Global Headquarters in Deerfield, Illinois. Your employment commencement date
will be not later than November 20, 2017 or such earlier date as you are available to commence employment (“Start Date”). 
 Your annualized
target compensation opportunity will be as follows: 
 Annualized Compensation (Target Opportunity) 

 

			
	 Annual Base Salary
	  	$1,450,000
	  
 Annual Incentive Plan
(Target - 150%*)
	  	$2,175,000
	  
 Target Annual Long-Term
Incentive Range**
	  	$4,500,000 - $9,000,000 - $13,500,000
	  
 Total Target Compensation
Opportunity
	  	$8,125,000 - $12,625,000 - $17,125,000

 *    Target as a percent of Annual Base Salary. 

**    The value of the long-term incentive grants reflects the range (i.e., minimum, midpoint and maximum) for the target value of your
annual equity grants. The actual number of shares, units, or options will be determined pursuant to the Company’s specific valuation methodology (e.g., Black-Scholes value for stock options). 

Your Annual Base Salary will be subject to an annual review by the Board and increase in the Board’s sole discretion. 

  
 1 

  
 

 
  

 Annual Incentive Plan 

You will be eligible to participate in the Mondelēz International Management Incentive Plan (the “MIP”), the Company’s annual incentive
program. Your target award opportunity under the MIP is equal to 150% of your Annual Base Salary. The actual amount you will receive may be lower or higher, depending on your individual performance and the Company’s overall performance during
the year. The maximum award under this program for 2017 is 200% of your target opportunity and the Company reserves the right to change the maximum award annually (but not the target opportunity unless otherwise mutually agreed to), but, for a
reduction, only to the extent consistent with reductions for other senior executives. For the 2017 MIP plan year ending on December 31, 2017, your award will be prorated based on 6 months of eligibility, and your actual award will ultimately be
determined based on your individual performance during your period of employment and the Company’s actual overall performance for the full 2017 plan year. 

Long-Term Incentives (Annual Equity Program) 
 You
will be eligible to fully participate in the Company’s annual equity program. Equity grants are typically made annually in February. For 2017, grants were delivered with 75% of the grant value in performance share units and 25% of the grant
value in stock options (with the actual number of shares, units, or options determined pursuant to the Company’s specific valuation methodology). Your first full grant under the Company’s standard annual equity program will be awarded to
you in February 2018 and will have a target value of not less than $9,000,000 on the date of grant, using the Company’s specific valuation methodology. Thereafter, your actual target equity grant value is based on your individual performance in
accordance with the applicable range. 
 All equity grants are subject to the terms and conditions of the Company’s Amended and Restated 2005
Performance Incentive Plan (“Plan”) and the applicable annual grant agreements. The annual equity program described above is based on our current design and the Company reserves the right to change the annual equity program at any time.
However, provided you remain continuously employed from the Start Date, upon attaining age 65, you will be deemed retirement-eligible for purposes of all outstanding long-term incentive grants. 

Make Whole Award 
 As part of your offer of
employment, and to make up for compensation forfeited at your previous employer, on the Start Date you will receive a make whole award with a target value of $38,000,000; provided, however, if any of your outstanding incentive awards, except your
annual bonus, vest or are otherwise paid to you in conjunction with your departure from your previous employer, then such make whole award shall be reduced dollar for dollar by the gross amount recognized (as converted into United States dollars on
the payment date) by you on a weighted-basis across the allocations specified below. 

  
 2 

  
 

 
  

 The make whole award will be allocated as follows (with the deferred stock units and performance share units
granted under the Plan and the actual number of units determined pursuant to the mutually agreed upon valuation methodology): 
  

	 	•	 	Cash payment of $10,000,000 payable as soon as practicable after your Start Date. The cash award will be payable in a lump-sum subject to a full repayment upon an involuntary
termination of employment for Cause or a voluntary termination other than for Good Reason (and other than due to death or Disability) (each such capitalized term as defined below) prior to January 1, 2019, and on a prorated basis for such a
termination occurring upon or after January 1, 2019 and prior to the second anniversary of the Start Date with such proration fraction based on (i) the number of days from the date of termination to the second anniversary of the Start Date
divided by (ii) 730. 

  

	 	•	 	$18,000,000 in deferred stock units, granted on the Start Date, that vest 15% on December 1, 2017, 25% on the first anniversary of the Start Date and 60% on the second anniversary of the Start Date. Other than the
vesting schedule specified here and as provided below for certain terminations of employment, these deferred stock units will be subject to all other terms and conditions set forth in the Plan and the Company’s standard Global Deferred Stock
Unit Agreement as in effect on the date hereof. 

  

	 	•	 	$10,000,000 in performance share units, granted on the Start Date. These performance share units will be subject to the achievement of financial results, which are based on adjusted earnings per share growth and organic
revenue growth over the performance period, that have been provided to you separately. The performance period for these units will be the one-year period beginning January 1, 2018 and ending on
December 31, 2018 and will be subject to a service-based vesting requirement until January 1, 2020. You will receive accumulated dividend equivalent payments at the time of vesting based on the actual number of shares vested. Other than
the vesting schedule and performance period specified here and as provided below for certain terminations of employment, these performance share units will be subject to all other terms and conditions set forth in the Plan and the Company’s
standard Global Long-Term Incentive Grant Agreement as in effect on the date hereof. 

 In addition, in the event that your 2017 fiscal year
annual bonus from your previous employer is forfeited, you will receive a lump sum cash make whole award in the amount of $2,404,325 (which make whole award will be reduced by the gross amount (as converted into United States dollars on the payment
date) of such bonus that you receive from your previous employer). 
 In recognition of you not receiving a long-term incentive award from your current
employer in 2017, you will also be granted an equity award with a target value of $4,500,000 upon hire. This award will be structured consistent with our annual grant practice in 2017. Specifically, you will receive 75% of

  
 3 

  
 

 
  

 
the award in performance share units and 25% in stock options. In regards to the performance share units, the actual number of shares received at the conclusion of the performance cycle will be
based on the 2017-2019 performance cycle. This award will fully vest in the first quarter of 2020. In regards to the stock options, the options will vest as follows: 33% on February 16, 2018, 33% on February 16, 2019 and 34% on
February 16, 2020. Other than the vesting schedule specified here and as provided below for certain terminations of employment, these performance share units and stock options will be subject to all other terms and conditions set forth in the
Plan and the Company’s standard Global Long-Term Incentive Grant Agreement and Non-Qualified Global Stock Option Agreement. 

Furthermore, solely for the awards listed under this Make Whole Award section above, upon an involuntary termination without Cause or your resignation for
Good Reason, or due to your death or Disability, occurring at any time during the applicable vesting periods for these awards (including any applicable performance periods), you shall be treated as fully vested in the awards, contingent on your
executing and not revoking a general release of claims at the time and in the manner specified in Section 3.9 of the Mondelēz International, Inc. Change in Control Plan for Key Executives, as in effect on the date hereof (“CIC
Plan”) as if the benefits were made under the CIC Plan. For avoidance of doubt, the deferred stock units will fully vest on your termination date and will be paid shortly thereafter. The performance share units will vest on the original vesting
date and be based on actual performance for the applicable performance period, and will be paid shortly after the conclusion of the performance period in accordance with the terms of the agreement; provided, (i) for any such termination
occurring on or after December 31, 2018, the make whole performance share unit award above with a $10,000,000 target value will immediately vest on the date of termination in such amount as shall have been earned based on the achievement of the
applicable performance requirements during the performance period, and will be paid shortly thereafter; (ii) for any such termination occurring before December 31, 2018, the above performance share unit award with a $10,000,000 target
value will be subject to achievement of the applicable performance requirements during the performance period and will be paid following January 1, 2019 and no later than March 15, 2019; (iii) for any such termination occurring before
December 31, 2019, the above performance share unit award with a $3,375,000 target value will be subject to achievement of the applicable performance requirements during the applicable performance period and will be paid following
January 1, 2020 and no later than March 15, 2020 when such awards are paid to other executives; and (iv) for a termination due to death or Disability during the respective performance periods of such performance share unit awards,
such respective awards will be payable based on target performance. For the avoidance of doubt, the stock option award will vest on your termination date and be exercisable for the period specified in the Company’s standard Non-Qualified Global Stock Option Agreement based on an involuntary termination without cause. 

  
 4 

  
 

 
  

 For purposes of this Offer Letter: 
  

	 	•	 	“Cause” has the meaning set forth in the CIC Plan, except, that in lieu of clause (c) thereunder, such clause shall provide: your willfully engaging in other conduct which damages the Company in any
material respect (and for which purpose, no act or omission to act will be “willful” if conducted in good faith or with a reasonable belief that such act or omission was in the best interests of the Company). 

 

	 	•	 	“Good Reason” has the meaning set forth in the CIC Plan and, in addition, shall include the Board failing to appoint you as Chairman of the Board by April 1, 2018 and failing to appoint you on the Start
Date and nominate you as a member of the Board thereafter (unless you voluntarily choose to not stand for re-election). For the avoidance of doubt, references to “prior to/at the time of the Change in
Control” under such CIC Plan definition will be disregarded. 

  

	 	•	 	“Disability” has the meaning set forth in the CIC Plan. 

 Executive Deferred Compensation Plan

 You will be eligible to participate in the Executive Deferred Compensation Plan. This program allows you to voluntarily defer a portion of your
salary and/or your annual incentive award to a future date. Additional information for this program can be made available upon request. 
 Severance;
Change in Control Plan 
 In the event that the Company involuntarily terminates your employment without Cause or you resign for Good Reason at any
time on or before the second anniversary of the Start Date, other than to the extent covered under the CIC Plan, you will receive the following separation benefits: 
  

	 	(i)	a lump sum cash severance payment within sixty (60) days following your termination date in an amount equal to two years of Annual Base Salary plus two times your Annual Incentive Plan target bonus amount; and

  

	 	(ii)	a pro rata Annual Incentive Plan bonus paid at the same time as employees generally based on (x) actual Company, as measured for executives generally, and individual performance to be determined to be no less than
the actual Company performance and (y) a proration fraction based on the number of days employed during the fiscal year of such termination. 

For any involuntary termination without Cause by the Company occurring after the second anniversary of the Start Date, you will be entitled to severance on
terms no less favorable than: 
  

	 	(i)	a lump sum cash severance payment within sixty (60) days following your termination date in an amount equal to two years of Annual Base Salary only; and 

  
 5 

  
 

 
  

	 	(ii)	a pro rata Annual Incentive Bonus paid at the same time as employees generally based on (x) actual Company, as measured for executives generally, and individual performance to be determined to be no less than the
actual Company performance and (y) a proration fraction based on the number of days employed during the fiscal year of such termination. 

The foregoing separation payments are contingent on your executing and not revoking a general release of claims at the time and in the manner specified in
Section 3.9 of the CIC Plan as if the separation payments were made under such CIC Plan. 
 From your Start Date, you will be a participant in the CIC
Plan. The CIC Plan provides certain benefits upon an involuntary termination without Cause or voluntary termination for Good Reason following a Change in Control. A copy of the CIC Plan will be separately provided. In the event of any amendment to
the CIC Plan that is adverse to you or a termination of the CIC Plan, without your prior written consent in either case, for purposes of this Offer Letter, such amendment or termination will be disregarded. For the avoidance of doubt, if you become
entitled to severance pay under the CIC Plan, the severance pay amounts specified above will not be paid, and you will receive severance pay only under the CIC Plan. 

Stock Ownership Guidelines 
 You will be required
to attain and hold Company stock equal in value to eight (8) times your annual base salary at your Start Date. Under current guidelines, you will have five years from the Start Date to achieve this level of ownership. Stock held for ownership
determination includes common stock held directly or indirectly and unvested deferred stock units. It does not include stock options or unvested performance share units. The Company reserves the right to change the guidelines at any time. 

You will also be required to hold for a period of at least one year the “net” shares received upon vesting in the case of deferred stock units or
performance share units or exercise in the case of stock options, from the respective vesting or exercise dates. 
 Net shares are the number of shares
resulting from the vesting of deferred stock units or performance share units or the exercise of stock options reduced by the number of shares required to satisfy any applicable tax withholding or costs associated with the respective vesting or
exercise. 

  
 6 

  
 

 
  

 Other Benefits 

You will be eligible for relocation benefits for your move to the Chicago area pursuant to the Company’s standard relocation policy for executives at
your level. 
 If needed, you will receive international tax preparation services for up to 3 calendar years through the Company’s expatriate tax
preparation services provider, KPMG. The cost of such tax preparation services shall not count against any reimbursement under the Company’s discretionary financial planning program described below. 

Under the current policies in place, which are subject to change, you will be eligible for the Company’s discretionary financial planning program, which
reimburses you up to $10,000 per year for eligible financial planning expenses, and car allowance program, which provides a car allowance of up to $23,333 per year. You will also have access to the Company-leased aircraft for personal usage,
however, you shall be individually responsible for any and all associated federal and state taxes due to imputed income for such personal usage. 
 You will
be eligible for Mondelēz Global LLC’s comprehensive benefits package available to full-time salaried U.S. employees. You will be eligible for 30 days of paid time off annually. Details and terms of these comprehensive benefits will be
provided separately. 
 The Company will pay your reasonable professional fees incurred to negotiate and prepare this Offer Letter. 

Restrictive Covenants 
 As a condition to this
offer of employment and corresponding consideration, you agree to the terms and conditions of the Confidential Information, Intellectual Property and Restrictive Covenants Agreement (the “Covenant Agreement”) attached hereto as
Appendix A and will acknowledge such Covenant Agreement by signing the Covenant Agreement simultaneously with this offer of employment. 

Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) 

No amount hereunder or under any other agreement that is subject to Code Section 409A (“Section 409A”) shall be payable upon a termination
of your employment unless such termination constitutes a “separation from service” with the Company under Section 409A. To the maximum extent permitted by applicable law, amounts payable to you pursuant to this Offer Letter shall be
made in reliance upon the exception for certain involuntary terminations under a separation pay plan or as short-term deferral under Section 409A. For purposes of Section 409A, your right to receive any installment payments shall be
treated as a right to receive a series of separate and distinct payments. To the extent any amount payable to you is subject to your entering into a release of claims with the 

  
 7 

  
 

 
  

 
Company and any such amount is a deferral of compensation under Section 409A and which amount could be payable to you in either of two taxable years, such payments shall be made or commence,
as applicable, on the first date otherwise payable but in the later such later taxable year and shall include all payments that otherwise would have been made before such date. 

If you are a “specified employee” (within the meaning of Section 409A) as of your separation from service (within the meaning of
Section 409A): (a) payment of any amounts under this Offer Letter (or under any severance arrangement pursuant to this Offer Letter) which the Company determines constitute the payment of nonqualified deferred compensation (within the meaning
of Section 409A) and which would otherwise be paid upon your separation from service shall not be paid before the date that is six months after the date of your separation from service and any amounts that cannot be paid by reason of this
limitation shall be accumulated and paid on the earlier of (x) your death and (y) the first day of the seventh month (or as soon as administratively possible thereafter) following the date of your separation from service (within the
meaning of Section 409A); and (b) any welfare or other benefits (including under a severance arrangement) which the Company determines constitute the payment of nonqualified deferred compensation (within the meaning of Section 409A)
and which would otherwise be provided upon your separation from service shall be provided at your sole cost during the first six-month period after your separation from service and, on the first day of the
seventh month following your separation from service (or as soon as administratively possible), the Company shall reimburse you for the portion of such costs that would have been payable by the Company for that period if you were not a specified
employee. 
 Payment of any reimbursement amounts and the provision of benefits by the Company pursuant to this Offer Letter (including any reimbursements
or benefits to be provided pursuant to a severance arrangement) which the Company determines constitute nonqualified deferred compensation (within the meaning of Section 409A) shall be subject to the following: 

 

	(i)	the amount of the expenses eligible for reimbursement or the in-kind benefits provided during any calendar year shall not affect the amount of the expenses eligible for
reimbursement or the in-kind benefits to be provided in any other calendar year; 

  

	(ii)	the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the calendar year in which the expense was incurred; and 

 

	(iii)	your right to reimbursement or in-kind benefits is not subject to liquidation or exchange for any other benefit. 

The parties hereto intend that all compensation, benefits and other payments made to you hereunder will be provided or paid to you in compliance with all
applicable provisions, or an exemption or exception from the applicable provisions of Section 409A and the regulations and rulings issued thereunder, and the rulings, notices and other guidance issued by the Internal Revenue Service

  
 8 

  
 

 
  

 
interpreting the same, and this Offer Letter shall be construed and administered in accordance with such intent. The parties also agree that this Offer Letter may be modified, as reasonably
agreed by the parties, to the extent necessary to comply with all applicable requirements of, and to avoid the imposition of additional tax, interest and penalties under Section 409A in connection with the compensation, benefits and other
payments to be provided or paid to you hereunder. Any such modification shall maintain the original intent and benefit to the Company and you of the applicable provision of this Offer Letter, to the maximum extent possible without violating
Section 409A. 
 Indemnification; D&O Protection 

As an officer of the Company and member of the Board, you will be indemnified against various criminal or civil actions in accordance with the Company’s
Amended and Restated Articles of Incorporation and applicable law in a manner consistent with that provided for other senior executives of the Company and, if applicable, for other members of the Company’s Board of Directors. 

To the extent the Company maintains Directors and Officers liability insurance, you will be covered under that policy in a manner no less favorable than that
provided for other senior executives, and, if applicable, as other members of the Company’s Board of Directors. 
 You will enter into an
indemnification agreement with the Company in a form substantially similar to that signed by current members of the Company’s Board of Directors but modified to cover you with like force as an officer of the Company. 

Any entitlement to indemnification and/or coverage under the Company’s Directors and Officers liability insurance will survive a termination of your
employment, and conclusion of your service as a member of the Company’s Board of Directors, for any reason for such period of time thereafter during which you may be subject to liability for acts and omissions to act occurring during such
employment or service as a member of the Board. 
 Other Terms and Conditions 

You will be a U.S. employee of Mondelēz International, Inc. and your employment status will be governed by and shall be construed in accordance with the
laws of the United States. As such, your status will be that of an “at will” employee. This means that either you or Mondelēz International is free to terminate the employment relationship at that time, for any reason, subject to your
entitlements pursuant to this Offer Letter or any other plan or agreement applicable to a termination of your employment. 

  
 9 

  
 

 
  

 In the event of any inconsistency between this Offer Letter and any other plan, program, practice or
agreement in which you are a participant or a party, as in effect from time to time (collectively “Other Programs”), this Offer Letter will control, unless any applicable such Other Program either is more favorable to you or you agree in
writing that such Other Program controls. 
 The Offer Letter constitutes the entire agreement between the parties hereto (except to the extent other
agreements are specifically referenced herein to the extent not inconsistent with this Offer Letter) and supersedes any and all prior agreements and understandings, oral or written, relating to the subject matter hereof. The provisions of this Offer
Letter are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. This Offer Letter shall be binding upon and
inure to the benefit of any successors or assigns of the Company. 
 In the event of any dispute, other than under the Covenant Agreement, the Company will
pay your reasonable attorney’s fees and litigation costs of any dispute in which you prevail on any material issue; provided, however, if you do not prevail on any material issue, then you shall be responsible for the Company’s reasonable
attorney’s fees and litigation costs. 
 This Offer Letter shall be governed under and construed in accordance with the laws of the State of Illinois
without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdiction other than Illinois. Executive agrees that any legal proceeding concerning this Offer Letter may only be
brought and held in a state or federal court located in the State of Illinois. Executive consents to the personal jurisdiction of such courts and agrees not to claim that any such courts are inconvenient or otherwise inappropriate. 

  
 10 

  
 

 
  

 The offer under this Offer Letter is irrevocable and open for your acceptance until 5:00 Central Time on
July 28, 2017. Should you have any questions concerning this information, please call me. 
  

					
			
	 /s/ Mark D. Ketchum

Mark D. Ketchum
 Lead Director, Board of Directors

Mondelēz International, Inc.
	  		 	 July 27, 2017

Date

 I have read the above terms and conditions and, by signing below, do accept this offer. This letter does not, in any way,
constitute an express or implied contract for employment. 
  

					
			
	 /s/ Dirk Van de Put

Dirk Van de Put
	  		 	 July 28, 2017

Date

 [Signature Page to Mr. Dirk Van de Put Offer Letter] 

  
 11 

  
 

 
  

 APPENDIX A  

CONFIDENTIAL INFORMATION, INTELLECTUAL PROPERTY 

AND RESTRICTIVE COVENANTS AGREEMENT 

This Confidential Information, Intellectual Property and Restrictive Covenants Agreement (“Covenant Agreement”) is made between the
person specified in that certain offer of employment (“Executive”) and Mondelēz International, Inc. (and any currently or previously-affiliated companies, parent companies, successors or predecessors, including Mondelēz Global
LLC, Kraft Foods Inc., Kraft Foods Group, Inc., and Kraft Foods Global, Inc., hereafter, collectively, “MG”). 
 WHEREAS,
this Covenant Agreement is an extension of and incorporated into the offer of employment between Executive and MG under which MG desires and agrees to employ Executive and Executive desires and agrees to be employed by MG (the “Offer
Letter”); and 
 WHEREAS, as part of performing Executive’s responsibilities for MG, Executive will have access to
MG’s Confidential Information (as defined in Paragraph 2(a) below) and Intellectual Property (as defined in Paragraph 3(a) below). 

NOW, THEREFORE, for good and valuable consideration, including the promises and covenants contained in this Covenant Agreement,
including monetary consideration, Executive’s employment with MG and Executive’s access to and use of MG’s Confidential Information and Intellectual Property, MG and Executive hereby agree as follows: 

1.    Consideration. In addition to Executive’s employment with MG and Executive’s access to
and use of MG’s Confidential Information, as consideration for this Covenant Agreement, MG will provide Executive with such consideration described in the Offer Letter, including, but not limited to, any sign on incentives and participation in
the annual incentive plan and equity program. This Covenant Agreement shall control over any inconsistency with any other plan, program, practice or agreement providing for any covenant or restriction provided herein (and such other plan, program,
practice or agreement shall be disregarded unless Executive agrees in writing that such other plan, program, practice or agreement controls). 

2.    Confidential Information. 

(a)    Executive recognizes that MG derives economic value from information and trade secrets created
(whether by Executive or others) and used in MG’s business which is not generally known by the public, including but not limited to certain sales, marketing, strategy, financial, product, personnel, manufacturing, technical and other
proprietary information and material (“Confidential Information”) which are the property of MG. Executive understands that this list is not exhaustive, and that Confidential Information also includes other information that is marked or
otherwise identified as confidential or proprietary, or that would otherwise appear to a reasonable person to be confidential or proprietary in the context and circumstances in which the information is known or used. Executive expressly acknowledges
and agrees that, 

  
 1 

  
 

 
  

 
by virtue of Executive’s employment with MG, Executive will have access to and will use certain Confidential Information and that such Confidential Information constitutes MG’s trade
secrets and confidential and proprietary business information, all of which is MG’s exclusive property. For purposes of this Covenant Agreement, Confidential Information does not include information that is or may become known to Executive or
to the public from sources outside MG and through means other than a breach of this Covenant Agreement or disclosed by Executive after written approval from MG. 

(b)    Executive further understands and acknowledges that this Confidential Information and MG’s
ability to reserve it for the exclusive knowledge and use of MG is of great competitive importance and commercial value to MG. Executive agrees that Executive will treat all Confidential Information as strictly confidential and Executive will not,
and will not permit any other person or entity to, directly or indirectly, without the prior written consent of MG: (i) use Confidential Information for the benefit of any person or entity other than MG; (ii) remove, copy, duplicate or
otherwise reproduce any document or tangible item embodying or pertaining to any of the Confidential Information, except as required to perform Executive’s responsibilities for MG; and (iii) while employed and thereafter, publish, release,
disclose, deliver or otherwise make available to any third party any Confidential Information by any communication, including oral, documentary, electronic or magnetic information transmittal device or media. Notwithstanding the foregoing, Executive
shall be permitted to disclose, after (to the extent legally permissible) first providing reasonable written notice to MG’s Legal Department which allows MG the time and opportunity to object, Confidential Information to the extent
(x) required by law, subpoena, or applicable government or regulatory authority or (y) appropriate in connection with a legal dispute. 

(c)    Executive agrees and understands that the obligations under this Covenant Agreement with regard to
the non-disclosure and non-use of particular Confidential Information shall commence immediately upon Executive first having access to Confidential Information (whether
before or after Executive begins employment with MG) and shall continue to exist during and after Executive’s employment with MG for so long as such information remains Confidential Information and is not public knowledge other than as a result
of the Executive’s breach of this Covenant Agreement or breach by those acting in concert with Executive or on Executive’s behalf. 

(d)    Executive understands that improper use or disclosure of the Confidential Information by Executive
will cause MG to incur financial costs, loss of business advantage, liability under confidentiality agreements with third parties, civil damages and criminal penalties. 

3.    Intellectual Property. 

(a)    Disclosure and Assignment. Executive agrees to make prompt written disclosure to MG, to hold
in trust for the sole right and benefit of MG, and to assign to MG all Executive’s right, title and interest in and to any patents, trademarks, copyrights, ideas, inventions (whether 

  
 2 

  
 

 
  

 
not patented or patentable), original works of authorship (published or not), developments, improvements or trade secrets which Executive may solely or jointly conceive or reduce to practice, or
cause to be conceived or reduced to practice, during the period of Executive’s employment with MG and relating in any way to the business or contemplated business, research or development of MG (regardless of when or where the Intellectual
Property is prepared or whose equipment or other resources is used in preparing the same) (collectively “Intellectual Property”). Executive recognizes, provided prompt and full disclosure by Executive to MG, that this Covenant Agreement
will not be deemed to require assignment of any invention which was developed entirely on Executive’s own time without using MG’s equipment, supplies, facilities or trade secrets and neither relates to MG’s actual or anticipated
business, research or development, nor resulted from work performed by Executive (solely or jointly with others) for MG. 

(b)    Original Works. Executive acknowledges that all original works of authorship which have been
or are made by Executive (solely or jointly with others) within the scope of Executive’s employment with MG and which are protectable by copyright are the property of MG. To the extent that any such original works have not already been
transferred to or owned by MG, Executive hereby assigns all of Executive’s right, title and interest in those works to MG. 

(c)    Cooperation. Executive agrees to assist MG in every reasonable and proper way to obtain and
enforce United States and foreign proprietary rights relating to any and all patents, trademarks, inventions, original works of authorship, developments, improvements or trade secrets of MG in any and all countries. Executive will execute, verify
and deliver (i) such documents and perform such other acts (including appearing as a witness) as MG may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such proprietary rights and the
assignment thereof, and (ii) assignments of such proprietary rights to MG or its designee. Executive’s obligation to assist MG with respect to proprietary rights in any and all countries shall continue beyond the termination of employment.

 (d)    Other Obligations. In addition to Executive’s other obligations under this
Paragraph 3, Executive shall promptly disclose to MG fully and in writing all patent applications filed by Executive or on Executive’s behalf. At the time of each such disclosure, Executive shall advise MG in writing of any inventions that
Executive believes are not required to be assigned pursuant to this Paragraph. Executive shall at that time provide to MG in writing all evidence necessary to substantiate that belief. Executive understands that MG will keep in confidence, will not
disclose to third parties and will not use for any unauthorized purpose without Executive’s consent, any proprietary information disclosed in writing to MG pursuant to this Covenant Agreement relating to inventions that are not required to be
assigned pursuant to this subparagraph 3(d) and which were created or developed by Executive after termination of Executive’s employment. Executive will preserve the confidentiality of any such invention that is or may be required to be
assigned, in whole or in part, pursuant to this Paragraph 3. Executive agrees to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that may be required by MG) of all proprietary

  
 3 

  
 

 
  

 
information developed by Executive and all inventions made by Executive during the period of employment at MG, which records shall be available to and remain the sole property of MG at all times.
If MG becomes aware of a situation where it appears that its trade secrets are being used and/or disclosed by you, it will enforce its rights to the fullest degree allowed by law, including Federal or State trade secret law. An individual shall not
be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in confidence to a Federal, State, or local government official or to an attorney solely for the purpose of reporting
or investigating a suspected violation of law. An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a
lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the
trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. 

4.    Restrictive Covenants. Executive understands and agrees that the nature of Executive’s
position with MG provides Executive with access to and knowledge of MG’s Confidential Information and places Executive in a position of trust and confidence with MG. Because of MG’s legitimate business interests and for the consideration
afforded in this Covenant Agreement and Offer Letter, Executive agrees that during Executive’s employment with MG and for a period of twelve (12) months following the termination of Executive’s employment from MG for any reason (the
“Restricted Period”), Executive shall not engage in the following Prohibited Conduct: 

(a)    Non-Competition. Executive agrees that during the
Restricted Period and in any geographic area in which Executive directly or indirectly performed responsibilities for MG or where Executive’s knowledge of Confidential Information would be useful to a competitor in competing against MG,
Executive will not engage in any conduct in which Executive contributes Executive’s knowledge and skills, directly or indirectly, in whole or in part, as an executive, employee, employer, owner, operator, manager, advisor, consultant, agent,
partner, director, stockholder, officer, volunteer, intern or any other similar capacity to a competitor or to an entity engaged in the same or similar business as MG, including those engaged in the business of production, sale or marketing
of snack foods (including, but not limited to gum, chocolate, confectionary products, biscuits or any other product or service Executive had reason to know was under development by MG during Executive’s employment with MG) (“Competitive
Business”) without the written consent of MG’s Executive Vice President of Global Human Resources, or designee, such consent to be provided by MG in its sole and absolute discretion. Under no circumstances may Executive engage in any
activity that may require or inevitably require Executive’s use or disclosure of MG’s Confidential Information. 

(b)    Non-Solicitation of Customers or Accounts. Executive
understands and acknowledges that MG has expended and continues to expend significant time and expense in pursuing and retaining its customers and accounts, and that the loss of customers and 

  
 4 

  
 

 
  

 
accounts would cause significant and irreparable harm to MG. Executive therefore agrees that during the Restricted Period and for Executive or the direct or indirect benefit of any entity engaged
in the same or similar business as MG, including those engaged in the business of production, sale or marketing of snack foods (including but not limited to gum, chocolate, confectionary products, biscuits or any other product or service Executive
had reason to know was under development by MG during Executive’s employment with MG), Executive will not (i) solicit business from or perform services for, or for the benefit of, any customer or account of MG with which Executive had
contact, participated in the contact, or about which Executive had knowledge of Confidential Information by reason of Executive’s relationship with MG within the twelve (12) month period prior to Executive’s separation of employment
from MG, or (ii) solicit business from or perform services for, or for the benefit of, any customer or account MG actively pursued for business and with which Executive had contact, participated in the contact, or about which Executive had
knowledge of Confidential Information by reason of Executive’s relationship with MG within the twelve (12) month period prior to Executive’s separation of employment from MG. 

(c)    Non-Solicitation of Employees. Executive understands
and acknowledges that MG has expended and continues to expend significant time and expense in recruiting and training its employees, and that the loss of employees would cause significant and irreparable harm to MG. Executive therefore agrees and
covenants that during the Restricted Period Executive will not directly, or indirectly, solicit, hire, recruit, attempt to hire or recruit, or induce the termination of employment of any executive of MG. 

5.    Return of MG Property. Unless otherwise specified by MG in a separation or other similar-type
agreement, within five (5) days of Executive’s separation of employment from MG or as such other time as specified in the sole discretion of MG, Executive shall return all Confidential Information and all other MG property (whether in
electronic or paper form) in Executive’s possession, including documents, files, manuals, handbooks, notes, keys and any other items, files or documents (whether in electronic or paper form). 

6.    No Disparagement or Harm. Executive agrees that, in discussing Executive’s relationship
with MG and its affiliated and parent companies and their business and affairs, Executive will not disparage, discredit or otherwise refer to in a detrimental manner MG, its affiliated and parent companies or their officers, directors and
Executives. MG agrees that, in discussing Executive’s relationship with MG and its affiliated and parent companies and their business and affairs, MG (via any authorized public statement), officers or members of MG’s Board of Directors
will not disparage, discredit or otherwise refer to Executive in a detrimental manner. This Paragraph does not, in any way, restrict or impede Executive or MG (or its officers and directors), respectively, from exercising protected rights including
the right to communicate with any federal, state or local agency, including any with which a charge has been filed, to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order
of a court of competent jurisdiction or an authorized government agency, provided that such compliance does not exceed that required by the law, regulation or order. Respectively, Executive shall promptly provide written notice of any such order to
MG’s legal department and the Company shall promptly provide written notice of any such order to Executive. 

  
 5 

  
 

 
  

 7.    Remedies. Should Executive or MG breach any of
the provisions contained in Paragraphs 2 through 6 of this Covenant Agreement, in addition to any other remedies available to MG or Executive, as applies, if Executive is the breaching party, Executive will be obligated to pay back to MG any
payment(s) received pursuant to the Offer Letter. MG and Executive further acknowledge and agree that MG or Executive, as may apply, will or would suffer irreparable injury in the event of a breach or violation or threatened breach or violation of
the provisions set forth in this Covenant Agreement, and agree that in the event of a breach or violation of such provisions the aggrieved party will be awarded injunctive relief by a court of competent jurisdiction to prohibit any such violation or
breach, and that such right to injunctive relief will be in addition to any other remedy which may be ordered by the court or an arbitrator. The equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages or other
available forms of relief. 
 8.    Notification. Executive agrees that in the event Executive is
offered to enter into an employment relationship with a third party at any time during the Restricted Period, Executive shall immediately advise said other third party of the existence of this Covenant Agreement and shall immediately provide said
person or entity with a copy of this Covenant Agreement. 
 9.    Arbitration of Claims. In the
event either Executive or MG contests the interpretation or application of any of the terms of this Covenant Agreement, the complaining party shall notify the other in writing of the provision that is being contested. If the parties cannot
satisfactorily resolve the dispute within thirty (30) days, the matter will be submitted to arbitration. An arbitrator will be chosen pursuant to the American Arbitration Association’s (“AAA”) Employment Arbitration Rules and
Mediation Procedures. The arbitrator’s fees and expenses and filing fees shall be borne by MG. The hearing shall be held at a mutually agreeable location and the arbitrator shall issue a written award which shall be final and binding upon the
parties. Executive agrees to waive the right to a jury trial. Notwithstanding anything contained in this Paragraph 9, MG and Executive shall each have the right to institute judicial proceedings against the other party or anyone acting by, through
or under the other party, in order to enforce its rights under Paragraphs 2 through 6 through specific performance, injunction, or similar equitable relief. Claims not covered by arbitration are those claims seeking injunctive and other
relief due to unfair competition, due to the use or unauthorized disclosure of trade secrets or confidential information, due to wrongful conversion, breach of the Intellectual Property covenants, and the breach of the restrictive covenants set
forth in Paragraphs 2 through 6. 
 10.    Entire Agreement and Severability. This is the
entire agreement between Executive and MG on the subject matter of this Covenant Agreement. This Covenant Agreement may not be modified or canceled in any manner except by a writing signed by both Executive and an authorized MG official. Executive
acknowledges that MG has made no representations or promises to Executive, other than those in this Covenant Agreement. If any provision in this Covenant Agreement is found to be unenforceable, all other provisions will remain fully enforceable. The
covenants set forth in this Covenant Agreement shall be considered and construed as separate and independent 

  
 6 

  
 

 
  

 
covenants. Should any part or provision of any provision of this Covenant Agreement be held invalid, void or unenforceable in any court of competent jurisdiction, such invalidity, voidness or
unenforceability shall not render invalid, void or unenforceable any other part or provision of this Covenant Agreement. If the release and waiver of claims provisions of any agreement related to this Covenant Agreement are held to be unenforceable,
the parties agree to enter into a release and waiver agreement that is enforceable. 
 11.    Not a
Contract of Employment. Executive acknowledges and understands that nothing in this Covenant Agreement is intended to, nor should be construed to, alter the at-will nature of Executive’s
employment relationship with MG, nor to guarantee Executive’s employment for any specified term. Notwithstanding any provision of this Covenant Agreement, Executive and/or MG may terminate Executive’s employment at-will, for any reason permitted by law, with or without notice, and upon such termination, the rights and obligations set forth herein shall continue as expressly provided, subject to. 

12.    Tolling. Should Executive violate any of the terms of the confidentiality or restrictive
covenant obligations in this Covenant Agreement, the obligation at issue will run from the first date on which Executive ceases to be in violation of such obligation. 

13.    Attorneys’ Fees. Should either party breach any of the provisions of Paragraphs 2
through 6 of this Covenant Agreement, to the extent authorized by state law, the non-prevailing party (as determined by the trier of fact) will be responsible for payment of all reasonable attorneys’ fees
and costs that the prevailing party incurs in the course of such proceeding (including demonstrating the existence of a breach and any other contract enforcement efforts or successfully defending against an allegation of such breach). 

14.    Governing Law. This Covenant Agreement shall be governed under and construed in accordance
with the laws of the State of Illinois without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdiction other than Illinois. Executive agrees that any legal proceeding
concerning this Covenant Agreement may only be brought and held in a state or federal court located in the State of Illinois. Executive consents to the personal jurisdiction of such courts and agrees not to claim that any such courts are
inconvenient or otherwise inappropriate. 
 15.    Successors and Assigns. This Covenant Agreement
shall be binding upon, and inure to the benefit of, the parties and their respective successors and permitted assigns. Executive may not assign Executive’s rights and obligations under this Covenant Agreement without prior written consent of
MG. MG may assign this Covenant Agreement and/or its rights or obligations under this Covenant Agreement. Any and all rights and remedies of MG under this Covenant Agreement shall inure to the benefit of and be enforceable by any successor or
assignee of MG. 
 [Signatures are on the following page] 

  
 7 

  
 

 
  

 IN WITNESS WHEREOF, the parties agree that this Covenant Agreement is an extension of
and incorporated into the Offer Letter between Executive and MG, and the parties have executed this Offer Letter freely and voluntarily with the intention of being legally bound by it. 

 

			
	 MONDELEZ INTERNATIONAL,
INC.

		
	By:	 	/s/ Mark D. Ketchum
	Print Name:	 	Mark D. Ketchum
		
	Dated:	 	July 27, 2017

  

			
	 EXECUTIVE

		
	By:	 	Dirk Van de Put
	Print Name:	 	Dirk Van de Put
		
	Dated:	 	July 28, 2017

 [Signature Page to Confidential Information, Intellectual Property and Restrictive Covenants Agreement-
Appendix A to Dirk Van de Put Offer Letter] 

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]